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AB Clostridium difficile is one of the major public health treats nowadays as C. difficile 
infections (CDI) represent the majority of health-care associated infections. This is 
due to the standard treatment with broad-spectrum antibiotics, vancomycin and 
metronidazole. Treatment results in disrupted microbiota and that leads to decreased 
defence ability and increased reoccurrence of infections with C. difficile. Provided 
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antimicrobials are mostly directed towards peptidoglycan machinery involved in the 
last part of peptidoglycan biosynthesis. In this reason, Mur ligase are representing a 
great target for new antimicrobials as this first steps of peptidoglycan assembly are 
not targeted by antimicrobials yet. Mur ligases could be used as multi target drug to 
increase the therapeutic effectiveness. This study is focused on detection of new 
potential inhibitors of Mur ligases from C. difficile. Genes for Mur ligases were 
obtained from native and synthetic DNA. Mur ligases genes were cloned into 
appropriate vectors and expressed in prokaryotic and eukaryotic system. The goal 
was to obtain active, recombinant protein. This part of the study was rather 
unsuccessful with native origin of C. difficile DNA. This was not surprising as C. 
difficile is known as genetically difficult to modify. The further work was proceeded 
with synthetic DNA of Mur ligases. Proteins of interest were successfully expressed 
and purified. After purification, MurE protein was selected for further analysis. 
Purified MurE ligase was concentrated and positively tested for its activity. 
Afterwards, several inhibitors from genus Streptomyces and clinically used 
antimicrobials, fosfomycin and D-cycloserin, were used in last step of the study, 
inhibitory assay.  
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IJ en 
JI sl/en 
AI Bakterija Clostridium difficile v današnjem času predstavlja eno izmed večjih 
groženj javnemu zdravju, saj so infekcije s C. difficile eden od glavnih razlogov 
bolnišničnih okužb. Vzrok za to je predvsem zdravljenje infekcij s široko 
spektralnima antibiotikoma, vankomicinom in metronidazolom. Uporaba omenjenih 
antibiotikov podre ravnovesje črevesne mikrobiote in zmanjša zmožnost obrambe, 
ter posledično poveča možnost za ponoven pojav okužbe s C. difficile. Veliko 
zanimanje je zato usmerjeno v iskanje novih potencialnih tarč protimikrobnih 
sredstev, ki bi delovali bolj ozkospektralno in ne bi imeli velikega vpliva na črevesno 
mikrobioto. Mur ligaze so encimi, ki katalizirajo začetne korake sinteze 
peptidoglikana. Do sedaj znana antimikrobna sredstva so usmerjena predvsem na 
zadnje stopnje sinteze peptidoglikana, prvi koraki pa so še redko ciljani. V ta namen 
Mur ligaze predstavljajo velik potencial v iskanju novih protimikrobnih učinkovin. 
Ta študija se osredotoča na odkrivanje potencialnih inhibitorjev Mur ligaz iz C. 
difficile. Geni za Mur ligaze so bili pridobljeni iz naravne in sintetične DNA. Geni 
za Mur ligaze so bili klonirani v ustrezne vektorje za ekspresijo v prokariontskem in 
evkariontskem sistemu. Cilj je bil pridobiti aktivne rekombinantne Mur ligaze. Ta 
del študije je bil precej neuspešen z nativno DNA C. difficile. Nadaljnje delo je tako 
potekalo zgolj s sintetično DNA Mur ligaz. Ligaze so bile uspešno izražene in 
prečiščene. Po proteinski ekspresiji smo študijo osredotočili na MurE protein. 
Očiščeno MurE ligazo smo koncentrirali in testirali njeno aktivnost. S tem smo 
potrdili naše predvidevanje, saj smo pridobili aktivno, rekombinantno MurE ligazo. 
V zadnjem koraku študije smo izvedli test inhibicije z več različnimi inhibitorji iz 
rodu Streptomyces, ter dva antibiotika v klinični uporabi, fosfomicin in D-cikloserin. 
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ABBREVIATIONS AND SYMBOLS 
 
aa   amino acid 
Ap   ampicillin 
APS   ammonium persulfate 
ATP   adenosine triphosphate 
Bp   base pair 
BSA   bovine serum albumin 
CDI   Clostridium difficile infection 
Cm   chloramphenicol 
dH2O   distilled water 
DNA   deoxyribonucleic acid 
DNase   deoxyribonuclease 
dNTP   deoxynucleosyl triphosphate  
EDTA   ethylenediaminetetraacetic acid 
EPS   extracellular polysaccharide 
Gm   gentamycin 
His   histidine 
IMAC   immobilised metal chelating chromatography 
kb   kilobase pair 
kDa   kilodalton 
Kn   kanamycin 
LB   lysogeny broth 
LPS   lipopolysaccharide 
M   molar 
MRSA   meticilin resistant Staphylococcus aureus 
MurA    UDP-N-acetylglucosamine enolpyruvyl transferase 
MurB    UDP-N-acetylpyruvyl glucosamine reductase 
MurC    UDP-N-acetylmuramoyl:L-alanine ligase 
MurD    UDP-N-acetylmuramoyl:L-alanine:D-glutamate ligase 
MurE  UDP-N-acetylmuramoyl:L-alanine:D-glutamate:meso 
diaminopimelate ligase 
MurF  UDP-N-acetylmuramoyl:L-alanine:D-glutamate-meso-
diaminopimelate:D-alanyl-D-alanyl ligase  
NaCl   sodium chloride 
NaOH   sodium hydroxide 
nt   nucleotide 
OD600   optical density at 600 nanometres 
PEP   phosphoenolpyruvate 
PG   peptidoglycan 
PCR   polymerase chain reaction 
RNA   ribonucleic acid 
RNase   ribonuclease 
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rpm   revolutions per minute or rotations per minute 
RT   room temperature 
SDS   sodium dodecyl sulphate 
SDS-PAGE  sodium dodecyl sulphate polyacrylamide gel electrophoresis 
Sm   streptomycin 
spp.   species pl. 
TBE   tris/borate/EDTA 
TBS   tris buffered saline 
Tc   tetracycline 
TEMED  tetramethyl ethylenediamine 
Tris   Tris [hydroxyethyl] aminomethane  
tRNA   transfer ribonucleic acid  
U   enzyme unit 
UV   ultraviolet  
1 
Pušić M. Detection of potential, from Actinobacteria isolated, inhibitors of bacterium Clostridium difficile Mur ligases. 
   M.Sc. Thesis (Du2). Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2019 
 
1 INTRODUCTION 
 
Bacterium Clostridium difficile (C. difficile) is Gram positive, spore forming and toxin 
producing bacteria. Bacterium was recently, based on phylogenetic, phenotypic and 
chemotaxonomic analyses, reclassified to Clostridioides difficile. Both names are valid and 
in use (Oren and Rupnik, 2018). C. difficile is known to be a major cause of nosocomial 
diarrhoea. Diarrhoea and colitis are mediated with release of two exotoxins: enterotoxin 
toxin A and cytotoxin B (Ofosu, 2016). The worldwide rise of C. difficile infections (CDI) 
is accompanied by increased multidrug resistance and hypervirulent strains. Studies have 
shown that hypervirulent strains are responsible for more severe diarrhoea, increased 
mortality and more recurrent occurrences (Ezhilarasan et al., 2012). First in line for treatment 
of CDI are antibiotics metronidazole (used for un-severe infections) and vancomycin (used 
for severe infections). Both antibiotics mentioned are broad-spectrum and this represents the 
main problem of CDI. Besides C. difficile, metronidazole and vancomycin as well destroy 
normal gut microbiota and that results in decreased ability of defence against infection with 
C. difficile. In addition, antibiotics significantly increase the possibility for reoccurrence of 
CDI, which is one of the main clinical problems connected with CDI (Horvat and Rupnik, 
2018). Usage of metronidazole and vancomycin results in disturbance in gut microbiota, 
therefore allowing C. difficile to expand. It has been demonstrated by Horvat and Rupnik 
(2018) that C. difficile proliferates in both, healthy and dysbiotic (microbial imbalanced) 
microbiota. However, the extent of bacterial expansion is scientifically higher in dysbiotic 
microbiota. Authors have proven that C. difficile presence not only affects microbiota and 
but also increases the proportions of opportunistic pathogens.  
 
The increasing emergence of bacterial strains resistant to currently available antibiotics have 
created unmet medical needs in antibacterial therapy. Many decades after first patients were 
treated with antibiotics, bacterial infections become treat again. Alternative antibacterial 
agents are urgently needed. According to CDC Assessment of Antibacterial Resistance 
Treats C. difficile is rated as highest, urgent treat (Ventola, 2015). Development of novel 
effective antibacterial drugs directed toward previously unexploited targets is therefore 
essential to deal with bacterial drug resistance in the future.  
 
Rich source of new potential targets for antibiotic treatment is peptidoglycan biosynthesis. 
Peptidoglycan (PG) is essential component of bacterial cell wall and therefore drugs 
interfering the process of formation of peptidoglycans are very efficient. Key enzymes 
catalysing first steps of PG assembly are Mur enzymes and this enzyme family represents 
promising targets for the development of new inhibitors. MurA to MurF proteins are 
essential and highly conserved (Zoeiby et al., 2003). The idea behind is to find inhibitors 
that would recognize homologous binding motifs which would bind to more than one Mur 
ligase enzyme in the pathway having UDP-sugar as substrate.  
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1.1 AIM AND SCOPE 
 
1.1.1 Objectives 
The purpose of this work was to subclone native genes of Mur ligases from bacterium C. 
difficile into bacterium E. coli and to obtain and analyse the activity of Mur ligases from E. 
coli. More, Mur ligases were to express in insect cells. Mur ligases from insect cells were to 
obtain and the activity was to be examined as well. Method for a determination of in vitro 
inhibitory activity of potential inhibitors, isolated from Actinobacteria, of Mur ligases 
obtained from E. coli and insect cells, was to assemble. Third objective was the utilization 
of existed method of the detection of potential actinobacterial inhibitors of MurC and MurE 
ligases. 
The scope of research was expanded as wild-type DNA from C. difficile wanted to be 
compared to optimized, synthetic DNA of C. difficile. The extended purpose was to subclone 
the synthetic genes of C. difficile Mur ligases to E. coli and insect cells. Afterwards to obtain 
and to analyse the activity of Mur ligases from E. coli and insect cells. Moreover, we wanted 
to test potential inhibitors of Mur ligases with existing method of the detection and to 
determine in vitro inhibitory activity of potential inhibitors, isolated from Actinobacteria, 
towards the chosen ligase.  
 
1.1.2 Hypotheses 
The following hypotheses were set: 
-H0: Recombinant Mur enzymes can be purified while maintaining their activity. 
-H1.1.: In-vitro inhibitory activity can be achieved by several combinations of inhibitory 
tests. 
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2 LITERATURE REVIEW 
 
2.1 ANTIMICROBIAL AGENTS 
 
Antimicrobial agent is term used for drugs, chemicals or other substances that either kill or 
slow the growth of different microbes: bacteria (antibacterial drugs), viruses (antiviral 
drugs), fungi (antifungal drugs), protozoa (antiparasitic drugs), etc.  
 
Antimicrobial therapy is an essential and successful tool of modern medicine. However, 
antimicrobials do not provide complete protection against microbes, as they have shown 
great ability to avoid them (Greenwood et al., 2007). 
 
Antibacterial drugs 
Antibacterial drugs are the largest and most widely known class of antimicrobials. They are 
classified in several ways depending on spectrum of activity (broad spectrum or narrow 
spectrum), effect on bacteria (bactericidal, bacteriostatic, or combined both) or mode of 
action (Table 1). 
 
Table 1: Antibiotic mechanisms of action (Levy and Marshall, 2004)  
Preglednica 1: Mehanizmi delovanja antibiotikov (Levy in Marshall, 2004) 
Mechanism of action Antibiotic family 
Cell wall synthesis inhibition β-lactames (penicillins, cephalosporines, 
carbapenemes, monobactams) 
Protein synthesis inhibition aminoglycosides, ketolides, lincosamides, macrolides, 
oxazolidonones, streptogramins, tetracyclines 
DNA synthesis inhibition flouroquinolones 
Competitive inhibition of folic acid synthesis trimethoprim, sulphonamides 
RNA synthesis inhibition rifampin 
Other metronidazole 
 
 
 
Figure 1:  Antibiotic mechanisms of action and their targets (de Lima Procopio et al., 2012) 
Slika 1: Mehanizmi delovanja antibiotikov in njihove tarče (de Lima Procopio in sod., 2012) 
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2.2 ANTIMICROBIAL RESISTANCE 
 
Antimicrobial resistance (AMR) is the ability of a microorganism (bacteria, viruses, and 
some parasites) to prevent antimicrobial agents (antibiotics, antivirals and antimalarials) 
having inhibitory effect on them. As a result, standard treatments become ineffective, 
infections remain and can spread to others (WHO, 2018). Resistance became the most 
pressing issue in the field of antimicrobial treatment. The resistance evolution is frightening, 
as most antibacterial agents in use are or can become ineffective due to bacterial mechanisms 
of protection (Dax, 1994).  
 
According to World Health Organisation, antimicrobial resistance is present in every country 
and the biggest threats are resistance in bacteria (Klebsiella pneumoniae, E. coli, 
Staphylococcus aureus, Clostridium difficile, …), resistance in malaria, resistance in HIV 
and resistance in influenza. 
 
2.2.1 Mechanisms of resistance 
Mechanism of resistance to antimicrobials can be in general divided into two types: intrinsic 
and acquired resistance.  
 
Intrinsic resistance 
Intrinsic resistance is chromosomally encoded, and it is natural resistance possessed by most 
strains of bacterial species.  
 
An example is Pseudomonas aeruginosa, who is naturally resistant to many antimicrobials 
due to low membrane permeability (Abebe et al., 2016). 
 
Special intrinsic mechanisms involve absence of antibiotic target (ex. absence of cell wall in 
mycoplasma) or absence of metabolism needed for antibiotic activity (ex. aminoglycozides 
cannot target anaerobic bacteria or aerobic bacteria in anaerobic environment (abscesses). In 
these environments antibiotics cannot be transferred into cells as the transport is 
energetically demanded process occurring only in aerobic conditions). 
 
Acquired resistance 
Acquired resistance is resistance due to change in bacterial genome because of horizontal 
gene transfer or mutation. These mechanisms can result in a change of structural and 
functional properties of bacteria involved. 
- Horizontal gene transfer: mechanism for transfer of genetic material from donor to 
recipient chromosome into which resistance genes can be incorporated. Transfer can 
be done by three main mechanisms: transformation, conjugation and transduction. 
Antibiotic resistance is usually encoded on plasmids, transposons or integrons, which 
serve as vector of gene transfer between strains and species (Abebe et al., 2016). 
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- Mutational resistance: mutations in genes that affect the activity of the drug enable 
the cells to survive in the presence of the antimicrobial molecule. The antibiotic 
eliminates the susceptible population once a resistant mutant is formed, and the 
resistant bacteria becomes dominant (Munita and Arias, 2016). 
 
Generally, major mechanisms of active antimicrobial resistance are: 
 
1. Enzymatic inactivation of drug: 
modifying enzymes produced by 
bacteria destroy (ex. β-lactamases) 
or modify the drug. Enzymatic 
inactivation is due to hydrolysis or 
modification (Bockstael and 
Aerschot, 2009). 
 
2. Decreased drug uptake or 
increased efflux of the drug:   
 decreased drug uptake is 
caused by loss of 
transporters, lack of  
porins and different 
modifications of the channels;  
 efflux pumps (ex. resistance to 
tetracycline): efflux mechanism pump out antimicrobial agents before they reach 
target (Bockstael and Aerschot, 2009) 
 multidrug-efflux pump in Gram negative bacteria: a pumps complex that 
interacts with membrane proteins and forms multi-subunit complexes that 
effectively release drug molecules (Nikaido, 2001). 
 
3. Altering intracellular target of the drug: 
 target may be protected by protein which prevents the antibiotic reaching it (ex. 
quinolone resistance is based on protein Qnr protection); 
 target site can be refined and that results in decreased affinity for the antibiotic; 
 bypass of the target size or its complete replacement: bacteria can develop new 
targets that achieve similar biochemical functions to the original target but are 
not inhibited by the antimicrobial molecule (Fairlamb et al., 2016). 
 
2.3 ANTIBIOTIC RESISTANCE CRISIS 
 
Many years after antibiotic discovery and its successful treatment, bacterial infections have 
again become a treat. When bacteria change in response to use of antibiotics, which are used 
to prevent and treat bacterial infections, resistance develops. Multidrug-resistant bacteria are 
currently considered as an emergent global disease and a major public health problem (Roca 
Figure 2: Mechanisms of antimicrobial resistance (Singh et al., 
2014) 
Slika 2: Mehanizmi antimikrobne odpornosti (Singh in sod., 2014) 
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et al., 2015). Drug-resistant strains initially appeared in hospitals due to high use of 
antibiotics. Infections with them lead to longer hospital stays, higher medical costs and 
increased mortality. Some infections are becoming harder to treat as antibiotics become less 
or even ineffective. Resistance mechanisms are spreading globally over the world and 
became serious treat for our ability to treat common infections. Problem is so alarmistic, it 
can be said world is heading to a post-antibiotic era in which now minor infections could be 
lethal again, if measures will not be undertaken (WHO, 2018). 
 
2.3.1 Causes of the antibiotic resistance crisis 
The first major cause of antimicrobial resistance is overuse, which drives the development 
of resistance. Epidemiological studies have shown a direct correlation between antibiotic 
consumption and the emergence of resistant bacteria. Development of resistance is due to 
inappropriate prescribing, lack of awareness and wide availability in human medicine. As a 
solution, education programs for rational use, prescriptive guidelines and active reporting 
must be given strong consideration. 
 
The use of antibiotics in human medicine as the cause of the resistance crisis is followed by 
the use in animals as growth promoters, prophylaxis and for the treatment of infections in 
animals. This leads to a selective pressure on both commensal and on pathogenic 
microorganisms, which can then be transmitted to humans directly, through environmental 
pollution or via food chain.  
 
More, one of the major factors influencing the spread of resistance is also the environment 
in which antibiotics accumulate as a result of uncontrolled consumption or due to 
contamination at production sites (pharma industry). The accumulation of active ingredients 
selects resistant microorganisms and the environment becomes a reservoir of resistance 
genes. Therefore, many horizontal gene transfers occur, leading to the development of 
resistant strains. These risks should be addressed by improving industrial wastewater and 
decontamination systems. 
 
Effective strategy for combating resistant bacteria in the past was development of new 
antibiotics. However, antibiotics are no longer considered as economically wise and 
profitable for pharmaceutical industry as many other drugs. Due to lack of economic appeal 
in developing new antibiotic pharmaceutical companies no longer invest in them and there 
is no or few new available antibiotic treatments. To conclude, the effort on research and 
development of new antibiotics must increase (Roca et al., 2015; Ventola, 2015; Munita and 
Arias, 2016). 
 
2.4 BACTERIAL CELL WALL 
 
Cell wall is an essential and highly complex bacterial cell structure (Seltman and Holst, 
2013). Introduction of electron microscopy allowed the cell wall to be visualized. 
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Furthermore, electron microscopy enabled the isolation of pure cell wall preparation for 
research (König et al., 2010). 
 
Main cell wall functions are: 
- provides shape of bacteria, 
- enables transport from outside to inside, 
- separates the interior of the bacteria from environment, 
- protection against changes in environment (osmotic pressure) (Seltman and Holst, 
2013). 
 
Gram stain - differentiation method 
The cell wall properties allowed a development of a method, which provides the 
differentiation of bacteria. Gram (1884) incidentally invented a simple staining method, 
allowing differentiation of bacteria into two large groups. The principle of Gram stain is 
based on the binding of purple and safranin dyes to the components in the bacterial cell. 
Undertake the method bacteria appearing dark blue to violet are classified as Gram positive, 
red ones as Gram negative. The difference in stainability is due to different structure of their 
cell wall. Gram positive cell wall is much ticker and contains more lipid than protein in 
comparison to a Gram-negative wall. Gram positive cell wall is composed largely of 
peptidoglycans (PG) on which different polymers (teichoic acid, peptidoglycolipids and 
polysaccharides) are attached. In contrast, Gram negative cell wall is thin. Outside the layer 
is an outer membrane, group specific component which is noncovalently linked to 
lipoprotein molecules, which are then covalently linked to PG. The damage caused to Gram 
negative bacteria by decolourizer is extensive and allows all purple dye to be washed away. 
(Seltman and Holst, 2013; Baron, 1996; Mohan, 2009).   
 
 
 
 
 
 
 
 
 
Figure 3: Bacterial cell wall structure (Mohan, 2009) 
Slika 3: Struktura bakterijske celične stene (Mohan, 2009)  
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2.4.1 Peptidoglycan structure 
Peptidoglycan (PG) is a rigid scaffold that provides structural integrity to the bacterial cell 
wall and is therefore essential for the survival of the bacteria. The PG structure is largely 
conserved and consists of sugar molecules and peptides. The process of biosynthesis is 
complex and involves up to 20 reactions taking place in the cytoplasm, followed by reactions 
on the inside of the membrane where lipid-linked intermediates are synthesized, and the last, 
polymerization reactions take place on the outer side of the cytoplasmic membrane 
(Barreteau et al., 2008). The glycan chains are formed of alternating N-acetylglucosamine 
(GlcNAc) and N-acetylmuramic acid (MurNAc) residues linked by β-1,4-glyosidic bonds. 
Glycan strands are cross-linked with peptides bonded to D-lactolyl group of MurNAc (Kirk 
et al., 2017). The chemical structure of PG layer in Gram negative and Gram positive bacteria 
is similar, although in Gram positive bacteria structure is more cross-linked and 
consequently ticker. Peptides contain L- and D- amino acids, its sequence and composition 
vary widely across bacterial species (Smith, 2006; Kirk et al., 2017). 
 
Looking closer at C. difficile PG, muropeptide analysis identified the tetrapeptide stem: L-
Ala-D-Glu-A2pm-D-Ala (A2pm: 2,6-diaminopimelic acid). Crosslinking of glycan strands 
in bacteria are catalysed by D,D-transpeptidases and most commonly occurs via 4-3 cross-
links. β-lactam antibiotics, such as penicillin, are primarily targeted to D,D-transpeptidases. 
However, C. difficile shows a high frequency of 3-3 peptide cross-links generated (catalysed 
by L,D-transpeptidases), which is increased by inhibition of D,D-transpeptidases by 
ampicillin and which suggests  L,D-transpeptidases are insensitive to ampicillin. 
Nonetheless, C. difficile is still susceptible to ampicillin, proposing that 4-3 linking is 
essential for PG assembly (Kirk et al., 2017). 
 
Further variations in PG structure between species are determined by N-deacetylation or O-
acetylation of GlcNAc or MurNAc. C. difficile has high levels of GlcNAc N-deacetylation, 
the proportion of N-deacetylation is higher than reported for other Gram positive bacteria 
(Kirk et al., 2017) 
 
Figure 4: C. difficile peptidoglycan structure (Kirk et al., 2017) 
Slika 4: Peptidoglikanska struktura bakterije C. difficile (Kirk in sod., 2017) 
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2.4.2 Peptidoglycan biosynthesis  
Peptidoglycan biosynthesis contains up to 20 steps, depending on the bacterial species. The 
synthesis involves a series of reactions leading from UDP-N-acetylglucosamine 
(UDPGlcNAc) to the completed UDPMurNAc-pentapeptide (UDPMurNAc-pept).  
Figure 5:  Peptidoglycan biosynthesis pathway (Smith, 2006) 
a. Structure of UDP-MurNAc-pentapeptide   b. Cytoplasmic steps in the biosynthesis of PG  
c. Membrane steps in the PG biosynthesis  
Slika 5: Biosintetska pot peptidoglikana (Smith, 2006) 
a. Struktura UDP-MurNAc-pentapeptida  b. Citoplazmatski koraki biosinteze peptidoglikana  
c. Membranski koraki biosinteze peptidoglikana 
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In first step, enolpyruvate residue of phosphoenolpyruvate (PEP) is added to the 3-hydroxyl 
of UDP-GlcNAc to produce enolpyruvyl-UDP-N-acetylglucosamine. Inorganic phospate 
(Pi) is released during the reaction. Step is catalysed by the enzyme MurA (UDP-N-
acetylglucosamine enolpyruvyl transferase). In Step 2, the pyruvyl moiety is reduced to a 
lactyl group using NADPH and a solvent-derived proton to form UDP-N-acetylmuramic 
acid (UDPMurNAc). This reaction is catalysed by the flavoprotein MurB (UDP-N-
acetylpyruvyl glucosamine reductase). Steps 3-6 (Figure 4) show that through these steps a 
five-residue polypeptide chain is sequentially added. These reactions are catalysed by four 
ATP-dependent amide bond ligases, also called Mur synthetases, MurC (UDP-N-
acetylmuramoyl:L-alanine ligase), MurD (UDP-N-acetylmuramoyl:L-alanine:D-glutamate 
ligase), MurE (UDP-N-acetylmuramoyl:L-alanine:D-glutamate:meso-diaminopimelate 
ligase) and MurF (UDP-N-acetylmuramoyl:L-alanine:D-glutamate-meso-
diaminopimelate:D-alanyl-D-alanyl ligase). MurC provides addition of L-alanine, Mur D of 
D-glutamic acid, then MurE adds a diamino acid, generally meso-diaminopimelic acid or L-
lysine, and MurD adds dipeptide d-Ala-D-ala on the D-lactoyl group of UDP-MurNAc.  
 
The steps mentioned so far take place in the cytoplasm of the cell. The following processes 
occur on the membrane. In Step 7, UDPMurNAc-pentapeptide is bound to a membrane-
bound lipid carrier molecule undecaprenol-phosphate. This step is catalysed by integral 
membrane protein MraY and product of reaction is Lipid I. Further, glycosyltransferase 
MurG catalyses Step 8 and transfers N-acetylglucosamine (GlcNAc) to Lipid I to form a β-
(1→4) linked disaccharide moiety GlcNAc-MurNAc-pentapeptide, Lipid II. Lipid II is the 
ultimate monomer unit of the final peptidoglycan polymer. It is translocated across the 
membrane and incorporated into the growing PG layer. It is suggested that the translocation 
of Lipid II is mediated by flippases. In Step 9, the formation of glyosidic linkages occurs 
between the disaccharide units. In Step 10, the cross-linking of the peptide tails and the 
cleavage from the lipid carrier take place. The final step involves regeneration of the 
undecaprenol-phosphate by UppP, specific lipid pyro phosphorylase enzyme (Smith, 2006). 
 
2.5 MUR LIGASE FAMILY 
 
The Mur ligase family is a group of enzymes essential for peptidoglycan biosynthesis 
(Zoeiby et al., 2003). The murA to murF genes are crucial in bacteria. In addition, Mur 
proteins are highly conserved among bacterial species as common structural motifs can be 
distinguished. Mur ligase family demonstrates modular structure in protein architecture. 
Molecules consist of three domains that allow specific molecular recognition of each 
individual UDP substrate. Structure consists of a N-terminal domain responsible for binding 
the UDP-substrate, a central domain, which is similar to the nucleotide-binding domains of 
ATP- or GTP-ases and C-terminal domain, involved in the binding of the incoming amino 
acid or dipeptide (Perdih et al., 2017).  
 
All Mur ligases are likely to work by a proposed analogous sequential enzymatic 
mechanism. First, the bound UDP-precursor reacts with the ATP molecule to create an acyl-
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phosphate intermediate, which upon the addition of the incoming amino acid, provides the 
tetrahedral reaction intermediate. In the last step, the dissociation of the phosphate group 
leads to a new UDP-precursor elongated by the amino acid (Perdih et al., 2017). 
 
Mur ligase family has been attractive to researchers for the last decade, as the need of new 
drug targets has been emerged. As result, novel classes of Mur inhibitors were discovered 
(Perdih et al., 2017). Many antibiotics in clinical use inhibit the later steps in peptidoglycan 
biosynthesis, therefore Mur enzymes, as part of earlier steps, are good potential antibacterial 
targets. None of the enzymes, involved in these steps, are inhibited by known antibiotics or 
any other drug, except for MurA, inhibited by fosfomycin.  
 
2.5.1 MurA 
MurA is a ligase that catalyses a rare biochemical process of enolpyruvyl transfer from PEP 
to an OH group with concomitant release of Pi. The addition-elimination reaction begins 
with addition of a proton to C3 of PEP, while 3’-OH group of UDP-GlcNAc is deprotonated 
and tetrahedral intermediate is established (Figure 5). Thereafter, Pi releases the intermediate 
and with this UDP-GlcNAc-enolpyruvate is produced (Barreteau, et al., 2008).  
 
 
 
 
Figure 6: Reaction mechanism of MurA enzyme (Barreteau et al., 2008) 
X, Y and Z represent side-chains associated in reaction 
Slika 6: Reakcijski mehanizem encima MurA (Barreteau in sod., 2008) 
X, Y in Z predstavljajo stranske verige vključene v reakcijo 
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2.5.1.1 Inhibitors of MurA 
 
MurA is the only cytoplasmic step enzyme inhibited with an antibacterial agent in clinical 
use, fosfomycin. 
 
2.5.1.1.1 Fosfomycin 
 
Fosfomycin is a broad-spectrum and naturally produced antibiotic from certain Streptomyces 
species. Fosfomycin inactivate MurA through binding to Cys-11 in the catalytic site of the 
enzyme (Eschenburg et al., 2005). It was used to treat paediatric gastrointestinal infections 
caused by Shiga-like toxin producing Escherichia coli and bacterial infections of the urinary 
tract (Zoeiby et al., 2003). Fosfomycin also shows a high frequency of resistance 
development. Resistant strains have an impairment in fosfomycin uptake, overproduction of 
the enzyme or a low-affinity transferase enzyme. In some isolates, the enzymatic 
modification of the antibiotic causes’ plasmid-encoded resistance. Since fosfomycin is 
important for the treatment of some infections, resistant strains have become a major 
problem in therapy. Therefore, recently new inhibitors of the E. coli MurA enzyme were 
found: a cyclic disulphide, a purine analogue and a pyrazolopyrimidine. However, inhibition 
by these tree compounds is not directed towards MurA, but act on level of MurA DNA, RNA 
and protein synthesis (Zoeiby et al., 2003). 
 
2.5.2 MurB 
MurB is essential for the viability of bacteria and therefore is an attractive target for the 
development of new potential inhibitor. As well, there is no homologue of MurB in 
eukaryotic cells (Yang et al., 2006). MurB is a flavoprotein that catalyses a sequence of two 
half-reactions. In the first half-reaction, 4-pro-S hydride from NADPH is transferred to N-5 
of Enz-FAD (reduction by two-electron transfer from NADPH). The release of NADP+ 
follows the binding of UDP-GlcNAc-enolpyruvate. The second half-reaction is the hydrid 
transfer from Enz-FADH2 to C3 of the UDP-GlcNAc-enolpyruvate. This reaction is 
followed by quenching at C2 by a solvent-exchangeable proton to obtain the D-configuration 
of the lactyl ether product (Barreteau et al., 2008).  
 
Cristal structures of unliganded MurB and of its complex have been solved. Protein contains 
three domains: domains 1 and 2 mediate FAD binding, and domain 3 moderates the binding 
of its substrates (Barreteau et al., 2008). 
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2.5.2.1 Inhibitors of MurB 
 
A new class of small molecule inhibitors of MurB, tri-substituted thiazolidinone, have been 
identified. They were designed to mimic the diphosphate moiety of UDP-GlcNAc-
enolpyruvate. What is more, as their bioisosteric replacement, a series of imidazolinone 
analogues were developed (Zoeiby et al., 2003; Barreteau et al., 2008; Bronson et al. 2003).  
 
In addition, several chemical inhibitors of MurB have also shown good activity against 
MurB: 4-Alkyl and 4,40-dialkyl 1,2-bis-(4-chlorophenyl)-pyrazolidine-3,5-dione 
derivatives and a series of 3,5-dioxopyrazolidines, which have a good potential as inhibitors 
because they occupy the same region of the MurB active site as the N-acetyl group of the 
substrate (Kutterer et al., 2005; Yang et al., 2006).  
 
 
 
Figure 7: Reaction mechanism of MurB enzyme (Barreteau et al., 2008) 
(a) The first half reaction 
(b) The second half reaction 
Slika 7: Reakcijski mehanizem encima MurB (Barreteau in sod., 2008) 
(a) Prva polovična reakcija 
(b) Druga polovična reakcija 
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2.5.3 Mur synthetases  
Mur synthetases group consists of MurC, D, E and F, the four amino acid ligases. These 
enzymes are functionally similar to the ATP-dependent amide-forming enzymes, such as 
glutathione synthetase, glutamine synthetase, etc. 
 
Several studies have shown that Mur synthetases share three common features: 
- the same reaction mechanism, 
- a series of six invariant residues in addition to and ATP-binding consensus sequence, 
- similar three-dimensional structures in three domains: N-terminal domain, central 
domain and C-terminal domain. 
 
Due to above mentioned features, the Mur synthetases have a great potential for the design 
of multiple inhibitors which would target all four Mur ligases simultaneously. Potential 
multitarget drugs would increase the therapeutic effectiveness. So far, many MurC to MurF 
inhibitors have been researched and reported. However, most of them do not have 
antibacterial activity (Jukič, et al., 2018). 
Mur synthetases catalyse the formation of an amide or peptide bond, with concomitant ATP 
hydrolysis of ATP into ADP and inorganic phosphate (Pi). Essential for the reaction is a 
divalent cation, Mg2+ or Mn2+. The kinetic mechanism is ordered - beginning with ATP 
binding, followed by nucleotide substrate and ending with the amino acid or dipeptide 
binding. The first step is activation of the nucleotide substrate by ATP. Negatively charged 
groups of the ATP molecule and the nucleotide substrate were linked by two divalent cations. 
They also facilitate substrate binding and phosphorylation of the C-terminal carboxylate 
group of the nucleotide substrate. Therefore, an acyl-phosphate intermediate is formed. The 
amino group of the condensing amino acid substrate then replaces the phosphate by a Sn2 
nucleophilic attack to form a peptide bond and a tetrahedral intermediate, which breaks down 
into the lengthened peptide and Pi. For the formation of the peptide bond, a catalytic base is 
required to take up the proton from the charged amine group of the condensing amino acid.  
Figure 8: Reaction mechanism of Mur synthetases (Koudimi et al., 2014) 
Slika 8: Reakcijski mehanizem Mur sintetaz (Koudimi in sod., 2014) 
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However, it has been estimated that proton transfer is energetically highly demanded and 
therefore was suggested that amino acid substrate enters the reaction in deprotonated form 
to execute the nucleophilic attack (Kouidmi et al., 2014). 
 
Mur synthetases share the same three-dimensional structures. Each Mur ligase consists of an 
N-terminal domain that binds the nucleotide substrate, a central domain, binding the ATP 
molecule and UDP precursor, and a C-terminal domain, to which amino acid substrate binds 
(Kouidmi et al., 2014). Central and C-terminal domain show similar topologies in all Mur 
synthetases. However, N-terminal domain show differences related to the lengths of the UDP 
precursor substrates. These differences show that MurC and MurD are more similar to each 
other than are MurE and MurF to each other (Tomašić et al., 2012). 
 
2.5.3.1 Inhibitors 
 
The detailed kinetic mechanism and binding modes were investigated and the potential for 
development of multi-target Mur synthetases inhibitors was revealed. This strategy is 
promising, as resistance to multi-targets is less likely to develop, since at least two gene 
mutations in one generation should occur in order to maintain resistance (Tomašić et al., 
2012).  
Therefore, some multi target inhibitors were reported by Tomasić et al. (2018) - a series of 
thiazolidine-4-one inhibit as multitarget inhibitor or MurD-selective inhibitors.  
The ATP-binding domain shows highest similarity in sequence and structure; therefore, new 
compounds are made. Micromolar inhibitors of MurC and MurD with an N-acylhydrazone 
scaffold should target the enzyme ATP binding sites (Kouidmi et al., 2014). 
Phosphinate inhibitors, phosphinic acid derivates, are the best known inhibitors of Mur 
synthetases. X-ray diffraction analysis confirmed the characteristic of this inhibition in 
which the enzyme promotes transfer of the γ-phosphate from ATP on the phosphinate anion 
to produce ADP and a phosphorylated inhibitor. The result of the reaction is tetrahedral 
intermediate-like compound, phosphoryl phosphinate moiety. Phosphinate inhibitors were 
first developed for MurD. These are the first effective inhibitors of any of the steps in the 
synthesis of the UDP-N-acetylmuramic acid pentapeptide (Zoeiby et al., 2003). 
 
2.5.3.1.1 D-cycloserine 
 
D-cycloserine (DCS) is a natural product of Streptomyces lavendulae and Streptomyces 
garyphalus. It is known for its antibacterial properties. DCS interferes with peptidoglycan 
assembly and therefore inhibits bacterial growth. DCS targets two enzymes involved in the 
cytosolic stages of peptidoglycan biosynthesis: alanine racemase (Alr) and D-alanine:D-
alanine ligase (Ddl). The mechanism of action of both enzymes from numerous bacterial 
species is well studied. Alr is an enzyme that converts L-alanine to D-alanine. DCS targets 
Alr and that results in the formation of an aromatized DCS-PLP adduct that irreversibly 
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blocks Alr activity. Dlr generates D-alanine-D-alanine dipeptide on the C-terminus of 
pentapeptide chain of peptidoglycan monomers. DCS inhibits Ddl with competitive and 
reversible binding to one of the D-Ala binding sites on the enzymes. Since DCS has impact 
on bacterial cell-wall biosynthesis presents a great point for further therapeutic investigation 
on bacteria. DCS is also in clinical use as second line treatment of tuberculosis. (Batson et 
al., 2017; Prosser et al., 2013; Wargel et al., 1971)  
 
2.5.4 MurC 
MurC ligase catalyses the addition of the first amino acid of the peptide stem. For most 
bacteria, this amino acid is ʟ-alanine, in some rare cases and with lower efficiencies glycine 
or ʟ-serine are added. MurC activity is dependent on the presence of a reducing agent. Its 
kinetic mechanism was demonstrated. The reaction is reversible and sequential - first ATP 
is binding, second UPD-MurNAc and third ʟ-Ala. The exchange reaction is ADP and 
phosphate dependant (Barreteau et al., 2008). In E. coli has been shown that MurC is in 
balance between monomeric and dimeric forms in vitro. Therefore, the dimerization seems 
not to be important for the enzyme activity. It has also been shown that dimerization is 
present only in half of known protein sequences of MurC, that are absent in spore-forming 
bacteria, for example Clostridium and Bacillus spp. (Kouidmi et al., 2014).  
 
2.5.5 MurD 
D-Glutamic acid is only metabolised in prokaryotes and MurD has a high specifity for its D-
amino acid substrate making the ligase a promising target for inhibitors. Due to 
modifications at a later stage in biosynthesis, there are few exceptions such as D-
isoglutamine or threo-hydroxyglutamic acid. In contrast to MurC, here the exchange reaction 
is not ADP-dependant (Kouidmi et al., 2014; Barreteau et al., 2008).  
 
2.5.6 MurE 
Meso-diaminopimelic acid (Meso-A2pm) or ʟ-lysine is the third amino acid of the peptide 
stem and it is added with MurE enzyme. Typically, in Gram negative bacteria, bacilli and 
Mycobacteria Meso-A2pm residue occupy the third position of PG peptide unit, while Gram 
positive bacteria have a ʟ-lysine. In some species, there are several other amino acids as ʟ-
ornithine, ʟ-homoserine, ʟʟ-A2pm, meso-lanthionine, added by MurE. The incorporation of 
a correct amino acid, which is species specific, is critical as third residue of the PG peptide 
moiety takes part in glycan strand cross-linking and it maintains PG’s integrity. MurE is 
highly specific for the relevant amino acid and addition of wrong one leads to cell lysis. Its 
activation is guided by phosphate, a reaction product (Kouidmi et al., 2014; Barreteau et al., 
2008) 
 
2.5.7 MurF 
MurF catalyses the last cytoplasmic step of cell wall synthesis. Enzyme adds the residues at 
positions 4 and 5 as dipeptide D-Ala-D-Ala which is the most common combination. 
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Exceptions as D-Ala-D-Ser and D-Ala-D-Lac have been found in some strains. However, 
MurF accepts wider spectre of substrates than other Mur ligases, producing dipeptide from 
D-amino acids. The dipeptide added by MurF is essential for the PG synthesis because its 
peptide bond provides energy for the glycan strand cross-linking that takes place in the 
periplasm where no ATP is. Studies also show a sequential, ordered kinetic mechanism here. 
There are two equally effective forms of UDP-MurNAc-tripeptide (L-Lys and meso-A2pm) 
as substrates. Considering the pure enzyme, a high specifity of the C-terminal amino acid 
has been demonstrated (Kouidmi et al., 2014; Barreteau et al., 2008). 
 
2.5.8 MurG 
MurG or UDP-N-acetylglucosamine-N-acetylmuramyl-(pentapetide) pyrophosophoryl-
undecaprenol N-acetylglucosamine transferase is the only membrane bound enzyme from 
Mur ligase family and it is a part of the last step of peptidoglycan biosynthesis (Ezhilarasan 
et al., 2012). Accompanied by enzyme MraY, MurG catalyses the formation of lipid II from 
UDP-MurNAc-pentapeptide, UDP-GlcNAc and the lipid carrier undecaprenyl phosphate.  
 
First, MraY attaches UDP-MurNAc-pentapeptide to undecaprenol phosphate resulting in 
lipid I. Next, MurG enables the attachment of UDP-GlcNAc to lipid II, creating lipid II 
(Egan et al., 2015). 
 
 
Figure 9: Membrane steps in the bacterial cell wall biosynthesis (de Kruijff et al., 2008) 
MraY catalyses the formation of lipid I and MurG catalyses the formation of lipid II. Figure represents 
different antibiotics and their sites of action. D-cycloserine and fosfomycin inhibit the synthesis of UDP-
MurNAc-pentapeptide, which enters the membrane steps of PG biosynthesis. Further, Lipid II is 
attacked by many antibiotics such as vancomycin, nisin, etc. Bacitracin binds undecaprenyl phosphate. 
Penicillin and moenomycin inhibit the transpeptidase and transglucosylase of peptidoglycan.  
Slika 9: Membranski koraki biosinteze bakterijske celične stene (de Kruijff in sod., 2008) 
MraY katalizira nastanek lipida I, MurG pa katalizira nastanek lipida II. Slika prikazuje različne antibiotike in 
njihova mesta delovanja. D-cikloserin in fosfomicin inhibirata sintezo UDP-MurNAc-pentapeptida, ki vstopa 
v membranski del sinteze peptidoglikana. Lipid II je tarča mnogih antibiotikov, kot so vankomicin, nizin, itd. 
Bacitracin veže undekaprenil fosfat. Penicillin in moenomicin inhibirata peptidoglikansko transpeptidazo in 
transglikozilazo. 
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2.6 Clostridium difficile 
 
Clostridium difficile is an anaerobic and Gram positive bacterium that is the currently the 
most common cause of antibiotic-associated diarrhoea and it is one of the most frequent 
causes of health care-associated infections. C. difficile can be presented in human and animal 
gut as well. More, bacteria produce highly resistant spores that may be isolated from food or 
the environment. C. difficile colonizes gut after normal microbiota is disrupted, resulting in 
infectious diarrhoea, mediated by toxins. Most important risk factor of C. difficile infection 
(CDI) is the use of antibiotics, accompanied by hospitalization factor, advanced age (more 
than 65 years) and underlying disease (Smits et al., 2016). 16S ribosomal RNA sequencing 
proved that disruption of gut microbiota due to antibiotics usage highly contributes to CDI 
reoccurrence. Resistance to wide range of antibiotics allows C. difficile to colonize the gut 
even when antibiotics are used as treatment. Standard treatment of CDI includes broad-
spectrum antibiotics, oral vancomycin, metronidazole and clindamycin (Rupnik et al., 2009). 
First line treatment of CDI remaining effective for most of the cases. However, a lot of 
reduced susceptibilities has been reported, especially towards metronidazole as C. difficile 
has developed several mechanisms of resistance. Yet, the mechanism is not completely 
understood. It has been suggested that alternations are in nitroreductases, DNA repair, and 
iron uptake. Many factors can cause change, although the selective pressure caused by 
exposure to antibiotics is the most important one. Another important cause of resistance is 
biofilm formation. It is suggested that biofilms are responsible for metronidazole and 
vancomycin resistance emergence. The formation of biofilm is driven by intrinsic 
mechanisms and by the exposure to antibiotics. They protect pathogenic bacteria from 
environmental stress, such as antibiotic and that leads to an increase in their virulence and 
their survival. The resistance to antibiotics is increased from 10 to 1000-fold in bacteria 
existing in a biofilm in comparison to planktonic cells (Peng et al., 2017).  
Some of the most pressing issues connected with CDI treatments are management of 
multiple recurrences and management of severe complicated CDI. Patients most commonly 
positively respond to the treatment with vancomycin or metronidazole, however then the 
diarrhea symptoms often reappear within days to weeks after the treatment is stopped. In 
response to reoccurrence of symptoms, most of the time pulse dosing of vancomycin is used 
for preventing C. difficile to regrow and until normal flora recovers (Rupnik et al., 2009).  
Main reason for microbiota disruption and reoccurrences is use of broad-spectrum antibiotics 
for the treatment of CDI. Therefore, new antimicrobial agents with minimal impact on 
normal microbiota have been researched. Fidaxomicin, macrocyclic antibiotic with targeted 
bactericidal activity against C. difficile, is one of the newest agents approved for treatment 
of CDI and represents important development in the area. Fidaxomicin blocks gene 
transcription and suppresses toxin production, which contributes to better clinical response 
in comparison to vancomycin. shows potential advantages over other drugs for treatment of 
CDI. First, fidaxomicin is bactericidal, not bacteriostatic as vancomycin. More, fidaxomicin 
has lower MICs against C. difficile compared to other antibiotic used as treatment of CDI. 
As well it has a prolonged post-antibiotic effect and minimal side effects. Most important, 
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fidaxomicin has very narrow spectrum of activity in comparison to vancomycin and 
metronidazole. Consequently, there is less of an impact on the normal gut microbiota. 
Minimal effect on the microbiota reduces the risk of C. difficile colonization as commensal 
microbiota restores more rapidly (Mullane, 2014). Main disadvantage of fidaxomicin is its 
high price and many analyses have been conducted to confirm whether use of fidaxomicin 
is cost effective or not. Bartsch et al. (2013) proved that fidaxomicin treatment is not cost-
effective and should be considered when to be used in order to be beneficial. Antibiotic 
would become more cost effective if current price would decrease (Bartsch et al., 2013). 
C. difficile is resistant to multiple antibiotics commonly used for bacterial infections. 
Resistance not only leads to the occurrence and recurrence of CDI but also to the emergence 
of new strain types. A good example is a hypervirulent C. difficile BI/NAPI/027 strain, 
associated with overuse of fluoroquinolones. With epidemic strain BI/NAPI/027 it has been 
demonstrated that fluoroquinolone and macrolide overuse in patients increase the risk of the 
infection with C. difficile and consequentially mediates acquisition of fluoroquinolone 
resistance (Wieczorkiewicz et al., 2015).  
 
If C. difficile goes under the conditions that are not favourable for its growth, sporulation 
occurs. Metabolically dormant endospores are produced, providing protection of exposure 
to oxygen, heat, alcohol and certain disinfectants. Spores present in healthcare facilities can 
contaminate the environment and the material, leading to the spread of new infections and 
re-infections. However, in order to cause the disease, the spores must begin germination to 
return to the vegetative growth phase. Little is known about C. difficile germination. Bile 
salts (cholate, taurocholate, glycocholate and deoxycholate) are shown to stimulate the 
process of germination, although chenodeoxycholate, however another bile salt reflects, the 
inhibition of spore germination (Dembek et al., 2013).  
 
2.7 RECOMBINANT PROTEIN EXPRESSION 
 
Protein expression and purification has become an indispensable part in biochemistry 
research as well as for commercial applications. Recombinant protein expression can be 
carried out in prokaryotic system (ex. E. coli, Bacillus subtilis), eukaryotic system 
(mammalian and insect cells, yeast) or in vitro systems. Choosing the right organism for the 
expression is crucial. It defines the entire process, technology, molecular tools, equipment 
and reagent needed and used (Jia and Jeon, 2016). 
 
2.7.1 E. coli expression system 
E. coli has become the most popular expression system due to known advantages: 
 fast growth: in optimal conditions E. coli doubling time is about only about 20 
minutes, meaning stationary growth phase can be reached in just a few hours; 
 high cell density of the culture is easily attained; 
 growth media is easy to prepare and is inexpensive; 
 transformation with exogenous DNA is easy and fast.  
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On the other site the major disadvantage of using E. coli expression system is the lack of 
machinery used for post-translational modifications. Glycosylated proteins cannot be 
produced by this expression system. Therefore, some modification can be achieved by co-
expressing the corresponding enzymes. However, co-expression effects the growth rate of 
bacterial and some vectors cannot be co-expressed in a single strain (Jia and Jeon, 2016; 
Rosano and Ceccarelli, 2014). 
 
Available E. coli expression vectors are multiple and important is to choose a right one. 
Important features for successful vector selection are: 
 copy number of the vector: Higher protein yield is reached with high copy 
plasmids. However, the high plasmid number can trigger a metabolic burden, 
resulting in a decrease of protein synthesis. Nonetheless, high copy plasmids are 
highly desirable for the expression.  
 promoter: Effective promoter needs to be strong to allow the accumulation of 
recombinant protein, should have simple induction and its activity should be 
precisely tuned. Most often used are: 
 T7 promoter system: Present in the pET vectors. Gen of interest should be 
cloned behind a promoter and the entire system can be induced by lactose 
or its analogue isopropyl β-D-1-thiogalactropyranoside (IPTG). 
 lac promoter: One of the most researched arabinose promoters in pBAD 
vectors and phage promoters.  
 selection marker: The most used selection marker is antibiotic resistance. Mostly 
to ampicillin, chloramphenicol, kanamycin and tetracycline.  
 affinity tags: A good tag should provide easy detection of protein expression, high 
protein expression and solubility and easy isolation of highly pure proteins. 
Commonly, small peptide tags (ex. His tag) are used. Because of their small size 
they less like to interfere when bound to protein. In addition, commercial antibodies 
are available towards mentioned tags are available, so they can be easily detected by 
Western blot. As well, small tags allow simple affinity purification in one step. On 
the other hand, they sometimes have negative effect on biological activity or on the 
tertiary structure of the protein.  
 tag removal: Tags must be removed as they may interfere with protein activity. 
Therefore, enzyme digestion by several proteases as enterokinase, thrombin, factor 
Xa, is usually used.   
The appropriate host strain for the expression must necessarily be selected. The most 
important ones are BL21, BL21(DE3) and some derivates of the K-12 line.  
 
BL21 strains are commonly in use for their properties. They lack two important proteases, 
the Lon protease, which degrades foreign proteins, and the outer membrane protease OmpT, 
responsible for degradation of extracellular proteins. Consequently, lack of both proteases 
increases protein stability. Further, BL21 strains have hsdSB mutation that prevents plasmid 
loss. Most of the strains used for the protein expression are by far BL21(DE3), which contain 
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a gene forT7 RNA polymerase gene, which allows efficient expression under control of the 
T7 promoter (Gräslund et al., 2008).  
 
2.7.2 Baculovirus-infected insect cells expression system 
Baculovirus-infected insect cells are a very successful and widely used method of expression 
of numerous recombinant proteins. Then again, they are evolving even more as novel vector 
design and cell engineering approaches allow this expression system to increase its value 
even more. This expression system is commonly used for production of recombinant proteins 
due to proper post-translational modifications and high capacity for large inserts. They are 
biosafe and reach high yields because of strong promoters polyhedron or p10. Popular hosts 
for baculovirus are among the natural host insect, cell lines Sf-9 and Sf-21, derived from 
Spodoptera frugiperda and BTI-TN-5B1-4 derived from Trichoplusia ni (Hu, 2005). 
 
Despite the great success of protein expression with baculovirus-insect cell system, there are 
also some disadvantages. First, baculovirus infection results in cell lysis and death in a few 
days due to polyhedrin or p0. This has implications on the processing of proteins intended 
for plasma membrane or secretion. The problem can be solved with the use of early 
baculovirus promoters, resulting in more efficient processing of the glycoprotein. However, 
this also leads to lower expression level. What is more, glycosylation in insect cells differs 
in many aspects from glycosylation in mammalian cells. There appears to be no significant 
sialyation of N-glycans in insect cells, meaning glycoproteins produced by insect cells have 
extremely short half-lives in vivo and this is a huge barrier for use in therapeutics. Another 
disadvantage are the inefficient processing of proteins synthesised as large inactive precursor 
proteins (Hu, 2005). 
 
2.7.2.1 Bac-to-Bac expression system 
 
Bac-to-Bac expression system is based on the use of recombinant baculoviruses to infect 
insect cells to produce recombinant proteins. This system allows the easy generation of 
recombinant bacmid DNA with site-specific transposition of the Tn7 transposon.  
 
Components of the system are:  
 pFastBac1 plasmid, which contains the gene of interest and mini-Tn7 element.  
 DH10 Bac™ E. coli strain, which is a host strain for pFastBac1 construct and 
contains a baculovirus shuttle vector (bacmid) with a mini-att7 target site and a 
helper plasmid.  
 Baculovirus vector consists of kanamycin resistance, a low-copy number mini-F 
replicon and a LacZα segment in which attachment site for transposon Tn7 (mini-
attTn7) is inserted. 
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Recombinant bacmids are formed by transposition of mini-Tn7 element from donor plasmid 
to mini-attTn7 attachment site on the bacmid (Figure 10). Transposition is facilitated by 
transposition proteins of a helper plasmid.  Helper plasmid contains genes for the transposase 
providing the transposition, and gene for tetracycline resistance.  
Figure 10: Bac-to-Bac system diagram (Roest et al., 2016) 
Slika 10: Diagram Bac-to-Bac sistema (Roest in sod., 2016) 
 
After the transposition, isolation of recombinant bacmid DNA is possible, and further 
transfection into insect cells using the Cellfectin® II reagent can be performed 
(ThermoFisher, 2019b). 
 
After the recombinant bacmid DNA has been transfected to insect cells, a recombinant 
baculovirus particles are generated. Further, the viral titre is determined and baculoviral 
stock is used to infect insect cells to express recombinant protein. 
 
The blue-white screening 
After the transformation of donor vector to the DH10 Bac™ E. coli strain, it is necessary to 
confirm the right transformants, containing gene of interest. For the confirmation, the blue-
white screening is used. The donor vector has to encode the α-subunit of LacZ protein. The 
other omega subunit is encoded on the host strain. Both together form a functional β-
galactosidase. Vector also consists of multiple cloning site. Whether insert is incorporated 
within multiple cloning site of lacZα gene on the vector, the formation of functional β-
galactosidase is distorted. X-gal is a colourless modified galactose sugar and functions as 
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indicator. When hydrolysed by β-galactosidase causes characteristic blue colour in the 
colonies, meaning they contain vector without insert. On the other hand, white colonies show 
the successful insertion of DNA, as functionality of lacZα peptide was disrupted 
(Padmanabhan et al., 2011).  
 
2.8 PROTEIN PURIFICATION 
 
Protein purification is a widely used process in biochemical studies in industrial and 
academic settings. For the purification of recombinant proteins from bioprocess mixtures the 
affinity tag method is most frequently used. The use of peptide affinity tags fused to the 
protein, allows purification to be a powerful method.  
 
Immobilized metal-affinity chromatography 
Immobilized metal-affinity chromatography (IMAC) relies on the interaction between 
amino acid of the affinity tag and metal ions immobilized on a matrix. Most commonly used 
affinity tag consists of six histidine residues. A variety of immobilized metal matrices are 
available for use in IMAC. Most commonly used are nickel and cobalt based matrices. 
IMAC is a method that enables quick and successful purification in a single step. Affinity 
tagged protein purities can reach up to 95% purity with recovery of 90%. Poly histidine 
affinity tags are small and can be easily integrated into expression vector. Optimal placement 
of the tag is specific for each protein. Most commonly they are on N- or C- terminus of the 
proteins. Affinity tag can potentially influence protein activity. However, the poly histidine 
affinity tag is small and rarely affects protein activity. In addition, the tag can be inaccessible 
due to the protein folding. The problem can be easily solved by moving the affinity tag to 
opposite end or by implementing denaturing condition during the purification. For the 
purification of biologically active products the mild buffer conditions and imidazole as 
eluent, are often used. However, the purification using affinity tag can be performed also 
under denaturing conditions as 6 M guanidinium hydrochloride or 8 M urea during the 
purification. Disadvantage of the use of poly histidine affinity tags is nonspecific binding of 
untagged protein. Some cellular proteins may contain two or more alongside histidine 
residues, even although this is not common. These types of proteins then elute with protein 
of interest and affect the purity of final products. This problem is addressed more on 
mammalian systems rather than E. coli, as they have higher abundance of proteins with 
histidine residues. On the other hand, IMAC purification method possess strong advantages. 
Affinity tag is easily attached to the protein of interest and its small size ensures rarely 
affection on protein function. IMAC can provide high purities up to 95%. Poly histidine-
tagged proteins can retain biological activity since they can be eluted under mild conditions. 
After the interaction between protein of interest and matrix, the nonspecific proteins may be 
washed from the column. Imidazole in the wash buffer increases the stringency of the wash 
and elutes non-specific proteins more effectively. Various methods can be used for the 
elution of the protein of interest: lowering the pH, higher concentration of imidazole, use of 
chelating agents in the elution buffer. 
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Other purification methods 
After IMAC, proteins can be purified directly with other chromatographic methods. One of 
them can be size exclusion chromatography (SEC), which is based on the separation of 
molecules based on differences in size as they passed a resin packed in column. SEC resin 
is consisted of a porous matrix of spherical particles which minimize adsorption of 
biomolecules. The pores and space between particles are filled with the buffer. The buffer is 
stationary phase inside the pores is in equilibrium with the mobile phase outside the particles. 
Sample components are eluted isocratically. SEC is often used as polishing step of the 
purification and as an analytic technique for screening of aggregates in a given sample. The 
main advantage is the mild mobile phase conditions which provide minimal impact on 
conformational structure. SEC is based on the size of the protein, non-ideal interaction 
between molecules and the column materials. These interactions can affect the retention 
time, recovery of the protein and peak shape. In this method proteins interact with stationary 
phase which delay their retention times. 
 
SDS-page analysis is performed after the protein purification. Stained with dye (e.g. 
Coomassie brilliant blue), the intensity of the bands is normally proportional to the amount 
of protein. Protein concentration can be calculated with UV absorption measurement at A280 
(Bornhorst and Falke, 2000; Gräslund et al., 2008; Saraswat et al., 2013; Hong et al., 2012; 
GE Healthcare, 2001). 
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3 MATERIALS AND METHODS 
 
3.1 MATERIALS 
 
3.1.1 Bacterial strains 
This work was carried out using eight strains of bacterium Clostridium difficile, obtained 
from CCOS, Culture Collection of Switzerland.  
 
Table 2: List of bacterial strains of C. difficile used in the work and their labels 
Preglednica 2: Seznam bakterijskih sevov C. difficile uporabljenih v delu in njihove oznake  
Label of C. difficile strain used in the work 
CCOS-871 
CCOS-876 
CCOS-877 
CCOS-937 
CCOS-938 
CCOS-940 
CCOS-957 
CCOS-958 
 
3.1.2 Laboratorial bacterial strains 
 
Table 3:  List of laboratorial bacterial strains 
Preglednica 3: Seznam uporabljenih laboratorijskih sevov 
NAME OF THE 
STRAIN GENOTYPE PRODUCER 
SERIAL 
NUMBER 
DH10Bac™ Competent 
Cells 
F-mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 endA1 araD139 Δ(ara, leu)7697 galU galK 
λ-rpsL nupG/pMON14272/pMON7124 
Thermo Fisher 
Scientific 10361012 
BL21(DE3) 
Competent E. coli 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS; λ DE3 = λ 
sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
New England 
Biolabs, Inc  C2527I 
BL21 Competent E. coli fhuA2 [lon] ompT gal [dcm] ΔhsdS 
New England 
Biolabs, Inc  C2530H 
NEB® 10-beta 
Competent E. coli  
Δ(ara-leu) 7697 araD139  fhuA ΔlacX74 galK16 galE15 
e14-  ϕ80dlacZΔM15  recA1 relA1 endA1 
nupG  rpsL (StrR) rph spoT1 Δ(mrr-hsdRMS-mcrBC)  
New England 
Biolabs, Inc  C309I 
TOP10 Chemically 
Competent E. coli 
F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
Δ lacX74 recA1 araD139 Δ( araleu)7697 galU galK rpsL 
(StrR) endA1 nupG 
Thermo Fisher 
Scientific C404010 
 
3.1.3 Synthetic DNA 
Mur enzymes used for synthetic part of the experiment were ordered from GeneArt 
(Thermo Fisher). Sequences (Annex D) were codon optimized for the expression in E. coli 
and insect cells.  
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Table 4: List of synthetic genes of Mur ligases used in the work 
Preglednica 4: Seznam sintetičnih genov za Mur ligaze uporabljenih v tem delu 
GENE NAME GENE SIZE 
[bp] 
PRODUCER CONSTRUCT ID 
murE 1467 Thermo Fisher Scientific 18ABTUTP 
murF 1386 Thermo Fisher Scientific 18ABTUSP 
murG 1239  Thermo Fisher Scientific 18ABTURP 
 
As positive control of the experiment with synthetic DNA, MurD protein was used. 
Construct pPET28a::murD was provided by David Frasson, ZHAW School of Life Sciences 
and Facility Management, Department of Microbiology and Molecular Biology. Gene for 
MurD ligase was as synthetically provided and optimized for expression in E. coli and insect 
cells. 
 
3.1.4 Plasmids 
3.1.4.1 pET28a 
 
pET28a is a 5369 bp high copy bacterial expression plasmid with kanamycin resistance 
encoded. Plasmid is a part of pET series of vectors for high-yield expression. It has His tag 
on N-terminal and C-terminal, T7 promoter and multiple cloning site (MCS) allowing 
insertion of various genes of interest.  
 
3.1.4.2 pSIL 
 
pSIL is a 6883 bp high copy expression plasmid with ampicillin resistance encoded and 
polyhedrin promoter. Polyhedrin promoter controls the cloned Mur enzyme genes. Plasmid 
is derived from pFastBac Dual expression vector. Plasmid contains red fluorescent protein; 
expression of which is controlled by p10. RFP is used for the control of the expression of 
Mur enzymes. In case of successful expression, fluorescence can be detected under the 
microscope.  
 
3.1.4.3 pFastBac®  
 
pFastBac® is a 4800 bp expression vector for recombinant protein expression with 
ampicillin resistance encoded. It has polyhedrin promoter for high-level protein expression 
and lacZ gene used for blue-white screening.  
 
3.1.5 Culture media 
3.1.5.1 Liquid LB medium 
 
Liquid LB medium was prepared with 10 g/l of tryptone, 5 g/l of yeast extract and 5 g/l of 
NaCl dissolved in 500 ml of distilled water. The medium was autoclaved at 121°C. Liquid 
medium was stored at 4°C.  
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When needed the LB medium was supplemented with sterile filtered appropriate antibiotic: 
 5 ml of 100 mg/ml of ampicillin 
 2,5 ml of 10 mg/ml kanamycin 
 0,5 ml of 35 mg/ml chloramphenicol 
 
3.1.5.2 Solid LB medium 
 
Solid LB medium was prepared with 15 g/l of agar, 10 g/l of tryptone, 5 g/l of yeast extract 
and 5 g/l of NaCl dissolved in 500 ml of distilled water. The medium was autoclaved at 
121°C. Solidified medium was stored at 4°C. When needed, the LB medium was heated up 
until liquid and aseptically poured in Petri dishes. As well, the after the heating antibiotics 
could be added as described in Section 3.1.5.1.  
 
3.1.5.3 DH10™ Bac liquid medium  
 
DH10™ Bac liquid medium was prepared with 500 ml LB liquid medium (see Section 
3.1.5.1) and supplemented with 2,5 ml of 10 mg/ml kanamycin, 0,5 ml of 7 mg/ml 
gentamicin, 5,0 ml of 1 mg/ml tetracycline. 
 
3.1.5.4  DH10™ solid medium 
 
DH10™ Bac medium was prepared with 500 ml LB solid medium (see Section 3.1.5.2), 
heated up and supplemented with 2,5 ml of 10 mg/ml kanamycin, 0,5 ml of 7 mg/ml 
gentamicin, 5,0 ml of 1 mg/ml tetracycline, 1,25 ml of 40 mg/ml X-gal, and 0,835 ml of 40 
μg/ml IPTG. 
 
3.1.5.5 SOC medium 
 
SOC medium was prepared as solution containing deionized water, 2% of tryptone, 0,5% of 
yeast extract, 10 mM NaCl and 10 mM KCl. This solution was sterilized at 121°C. After 
autoclaving, the solution was cooled and 10 mM MgCl2 and 20 mM glucose were added.  
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3.1.6 Reagents 
 
Table 5: List of reagents used in the work 
Preglednica 5: Seznam reagentov uporabljenih v tem delu 
NAME PRODUCER SERIAL NUMBER 
Polymerase chain reaction     
Phusion® High-Fidelity PCR Master Mix with HF 
Buffer New England BioLabs® M0531L 
dH2O     
Agarose gel electrophoresis     
1 Kb Plus DNA Ladder (6x) Thermo Fisher 10787026 
Agarose Standard  Carl Roth 3810,3 
DNA Loading Dye (6X) Sigma O3756 
Ethidium bromide Sigma E1510 
Nanopure water *    
Rotiphorese® 50x TAE Buffer Carl Roth  CL.86.2 
Restriction digestion     
BamHI Roche  14317228 
dH2O   
HindIII Roche  10656321001 
NcoI Roche  19794321 
NdeI Roche  13643822 
StuI Roche  13365123 
SuRE/Cut™ Buffer B Roche  13917300 
SuRE/Cut™ Buffer H Roche  11420700 
XhoI Roche  13861225 
Ligation     
ligation buffer Roche  14028100 
T4 DNA Ligase Roche  14165157 
SDS-page     
10% APS  Sigma A3678 
Roti®-CELL 10x PBS  Carl Roth 9150 
10x TBS  BIO-RAD 1706435 
10x TGS Buffer BIO-RAD 1610732 
40% Acrylamide/Bis  BIO-RAD 1610146 
Coomassie Brilliant Blue R-250 BIO-RAD 1610436 
Destaining solution see Section 3.1.6.4  
Isopropanol Applichem A3928,1000 
Precision Plus Protein™ Dual Color Standards BIO-RAD 161-0374 
Roti®-Load 1    
Solution B see Section 3.1.6.5  
Solution C  see Section 3.1.6.6  
TEMED SIGMA-ALDRICH® 105K3720 
Western blot     
10x PBS  Carl Roth 9150,1 
Albumin Fraktion V. proteasefrei  Carl Roth  T844.2 
Anti-Mouse IgG Antibody QIAGEN 34660 
Nanopure water *    
Penta-His™ Antibody, BSA-free (100 μg) SIGMA-ALDRICH® A2304-1ML 
SuperSignal™ West Dura Trial Kit Thermo Scientific 37071 
(Continued) 
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Table 5: List of reagents used in the work 
Preglednica 5: Seznam reagentov uporabljenih v tem delu 
NAME PRODUCER SERIAL NUMBER 
Transfer buffer  see Section 3.1.6.9  
Insect cells     
Cellfectin® II Reagent Invitrogen 10362-100 
Plus™ Reagent Invitrogen 11514-015 
Sf-900™ II SFM (1X)  gibco 10902-096 
Isolation of recombinant bacmid DNA   
Solution I see Section 3.1.6.14  
Solution II see Section 3.1.6.15  
TE buffer see Section 3.1.6.16  
Potassium acetate Sigma P1190 
Protein purification     
20% EtOH   
cOmplete™, EDTA free Protease Inhibitor Cocktail SIGMA-ALDRICH® 56749-250G 
imidazole SIGMA-ALDRICH® 342483-500G 
Sodium chloride Carl Roth P029.2 
Sodium phosphate Roche 0-4693132001 
Size exclusion chromatography     
TRIS SIGMA-ALDRICH® 84415 
Ethanol Honeywell G3570 
Hydrocloric acid Sigma H1758 
Nanopure water *      
* Nanopure water - obtained with Ultrapure Lab water purification system form Sartorius. 
 
3.1.6.1 DNA 1kb Ladder working solution (6x) 
 
DNA 1 kb ladder working solution was prepared with 1 μl of DNA ladder (500 ng), 1 μl of 
10x BlueJuice Gel Loading Buffer and 8 μl of nuclease free water.  
 
3.1.6.2 DNA Loading Dye working solution (6x) 
 
DNA Loading Dye working solution was prepared with 10 mM Tris-HCl (pH 7.6), 0,03% 
Orange G, 0,03% xylene cyanol FF, 60% glycerol and 60 mM EDTA.  
 
3.1.6.3 10% APC for SDS-page analysis 
 
10% APS was prepared with 5 g of ammonium persulfate and nanopure water up to 50 ml. 
 
3.1.6.4 Destaining solution for SDS page-analysis 
 
Destaining solution (1 l) was prepared with 500 ml of nanopure water, 400 ml of NaOH 
and 100 ml of acidic acid.  
 
  
(Continuation) 
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3.1.6.5  Solution B for SDS-page analysis 
 
Solution B was prepared with 90. 9g of TRIS, 2 g of SDS, pH 8,8 and with nanopure water 
up to 500 ml. 
 
3.1.6.6 Solution C for SDS-page analysis 
 
Solution C was prepared with 30,3 g of TRIS, 2 g of SDS, pH 6,8 and nanopure water up 
to 500 ml. 
 
3.1.6.7 Running buffer for SDS-page analysis 
 
Running buffer for SDS-page analysis was prepared with 100 ml of 10x TGS Buffer and 
900 ml of nanopure water. 
 
3.1.6.8  SDS-page gels composition 
 
SDS-page gel composites of running and stacking gel. First, the running gel was prepared. 
All the ingredients are listed in Table 6. The addition of TEMED and APS results in quick 
polymerization of the gel, so these two reagents were added at the end. First stacking gel 
was mixed. Immediately after TEMED and APS were added, the gel was poured. 2 cm of 
free space below the top was left for the stacking gel. When the running gel was poured, 
isopropanol was placed on the top of the gel. Isopropanol prevents the formation of bubbles. 
The gel was completely polymerized in approximately 30 minutes. Isopropanol was 
removed, and the stacking gel was prepared. Stacking gel was poured on the top of the 
running gel and the comb was added immediately. As stacking gel was polymerized, the gel 
was prepared for the usage.  
 
All SDS-page analyses were performed with 12% SDS-page gel. 
Table 6: Composition of 12% SDS-page gel 
Preglednica 6: Sestava 12% SDS-page gela 
 Stacking gel  Running gel  
Solutions V = 2 ml Solutions V = 5 ml 
dH2O 1,26 ml dH2O 2,25 ml 
Solution C 0,5 ml Solution B 1,25 ml 
40% acrylamide 0,24 ml 40% acrylamide 1,25 ml 
10% APS 20 μl 10% APS 50 μl 
TEMED 2 μl TEMED 5 μl 
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3.1.6.9 Transfer buffer for Western blot analysis 
 
10x Transfer buffer for Western blot analysis was prepared with 30,4 g of Tris, 144,2 g of 
Glycine, 10,0 g of SDS and nanopure water up to 1000 ml (prepared without methanol). 
 
1x Transfer buffer for Western blot analysis was prepared with 100 ml of 10x Transfer 
buffer, 200 ml of methanol and 700 ml of nanopure water. 
 
3.1.6.10 Primary and secondary antibody solution for Western blot analysis 
 
The antibody solution for Western blot analysis was prepared as 3% BSA (0,6 g of BSA) in 
20 ml TBS. For the primary antibody solution Penta-His™ Antibodies, BSA-free (100 μg), 
Mouse monoclonal IgG were added and Anti-Mouse IgG antibodies for the secondary 
antibody solution. 
 
3.1.6.11 Binding buffer for protein purification 
 
Binding buffer for protein purification was prepared with 1,64 g of 20 mM sodium 
phosphate, 14,6 g of 500 mM NaCl, 0,68 g of 20 mM imidazole, adding HCl to adjust pH to 
7,4. 
 
3.1.6.12 Elution buffer for protein purification 
 
Elution buffer for protein purification was prepared with 1,64 g of 20 mM sodium phosphate, 
14,6 g of 500 mM NaCl, 17,02 g of 500 mM imidazole, adding HCl to adjust pH to 7,4. 
 
3.1.6.13 Elution buffer for size exclusion chromatography 
 
Elution buffer for size exclusion was prepared as 1 M Tris-HCl, pH 8,5. 
 
3.1.6.14 Solution I for isolation of recombinant bacmid DNA 
 
Solution I was prepared with 15 mM Tris-HCl, pH 8,0, 10 mM EDTA and 100 μg/ml 
RNase. 
 
3.1.6.15 Solution II for isolation of recombinant bacmid DNA 
 
Solution II was prepared with 0,2 M NaOH and 1% SDS.  
 
3.1.6.16 TE buffer 
 
TE buffer was prepared with 1 mM Tris-HCl, pH 8,0, 1 mM EDTA. 
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3.1.7 Enzymes  
Table 7: List of enzymes used in this work 
Preglednica 7: Seznam encimov uporabljenih v tem delu 
NAME OF ENZYME PRODUCER SERIAL NUMBER 
BamHI Roche  14317228 
HindIII Roche  14965221 
NcoI Roche  19794321 
NdeI Roche  13643822 
RNase, DNase free Roche  12029800 
StuI Roche  13365123 
T4 DNA Ligase Roche  14165157 
XhoI Roche  13861225 
 
3.1.8 Antibiotics 
Table 8: List of antibiotics used in the work 
Preglednica 8: Seznam antibiotikov uporabljenih v tem delu 
NAME OF THE ANTIBIOTIC PRODUCER SERIAL NUMBER 
Ampicilin Sigma A0166 
Chloramphenicol Sigma C1919 
D-cycloserine Sigma C6880 
Gentamycin Sigma G1264 
Kanamycin  Fluka 60615 
Phosphomycin disodium salt Sigma P5396 
Tetracyclin  Sigma T7660 
 
3.1.9 Chemicals 
Table 9: List of chemicals used in the work 
Preglednica 9: Seznam kemikalij uporabljenih v tem delu 
NAME OF CHEMICAL PRODUCER SERIAL NUMBER 
40% acrylamide and bis-acrylamide solution, 29:1 BIO-RAD 1610146 
Acidic acid  Carl Roth  6755,2 
Agarose Standard  Carl Roth  3810,3 
Albumin Fraktion V. proteasefrei  Carl Roth  T844.2 
Ammonium persulfate Sigma A3678 
Ethanol  Honeywell G3570 
Ethidium bromide Sigma E1510 
Glycerol AppliChem 7M011583 
Hydrochloric acid Sigma H1758 
Imidazole Sigma 56749-250G 
IPTG Sigma I6758 
Methanol  Sigma STBG1821V 
Natrium hydroxide  Sigma S8045 
Sodium chloride Carl Roth P029.2 
Sodium phosphate Sigma 342483-500G 
TRIS Sigma 84415 
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3.1.10 Kits 
Table 10: List of the kits used in the work 
Preglednica 10: Seznam kompletov uporabljenih v tem delu 
NAME OF THE KIT PRODUCER 
NucleoSpin® Gel and PCR Clean-up MACHEREY-NAGEL 
NucleoSpin® Plasmid MACHEREY-NAGEL 
PureYield™ Plasmid Maxiprep System  Promega   
S. aureus MurD Assay Kit Plus-100 ProFoldin  
E. coli MurE Assay Kit Plus-100 ProFoldin  
 
3.1.11 Laboratory equipment 
Table 11: List of laboratory equipment used in the work 
Preglednica 11: Seznam laboratorijske opreme uporabljene v delu 
NAME PRODUCER 
AlphaImager® HP Gel Imaging System Alpha Innotec 
Amicon® Ultra - 4  Merck Millipore Ltd.  
arium® pro VF Ultrapure Water system  Sartorius 
Automatic pipettes Gilson 
Automatic pipettes RAININ 
Biophotometer Eppendorf 
Centrifuge 5427 R Eppendorf 
Combs BIO-RAD 
Digital Sonifier® BRANSON 
Gel Caster BIO-RAD 
Heaseus Incubator Kendro Laboratory Products 
HisTrap™ FF crude GE Healthcare Bio-Sciences AB 
ImageQuant LAS 500 CCD imager GE Healthcare Bio-Sciences AB 
Incubation Shaker Multitron Standard INFORS HAT 
Inoculation loops VWR 
Inverted fluorescence microscope Leica 
Microcentrifuge tubes TreffLab 
Microwave MIOSTAR 
Minicoldlab 2023 (AKTA purifier) LKB 
Mini-PROTEAN® Tetra Vertical Electrophoresis Cell BIO-RAD 
MULTIFUGE 1 S-R Heraseus 
NanoDrop™® Spectrophotometer ND-1000 witec ag 
NucleoCounter® chemometec 
PCR Workstation C.B.S Scientific  
pH meter METTLER TOLEDO  
Power supply Model 1000/500  BIO-RAD 
PowerPacTM Basic Power Supply BIO-RAD 
PROTEAN® combs BIO-RAD 
Rotary shaker Digene 
S@femate ECO Class 1.8 Microbiological Safety Cabinet EuroClone® 
Scale KERN 
Scale METTLER TOLEDO  
Serological pipettes (2, 5, 20, 50 ml) Corning®  
spatula  VWR 
Sub-Cell GT UV-Transparent Gel Tray BIO-RAD 
(Continued) 
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Table 11: List of laboratory equipment used in the work 
Preglednica 11: Seznam laboratorijske opreme uporabljene v delu 
NAME PRODUCER 
Sub-Cell® GT Cell BIO-RAD 
Superdex 200 10/300 GL column GE Healthcare Bio-Sciences AB 
Thermocycler: Labcycler Basic & Gradient SensoQuest GmbH 
Thermomixer comfort Eppendorf 
TPP® tissue culture 6 well plate Sigma 
TPP® tissue culture flask 25 Sigma 
TPP® tissue culture flask 75 Sigma 
Tubes (13 ml) SARSTEDT AG&Co. KG 
Tubes (15ml and 50 ml) Corning® CentriStar TM 
Vortex Genie 2 Bender & Hobein AG 
Water bath Heto Lab equipment  
Water bath TW 20 JULABO 
Wide Mini-Sub Cell GT Cell BIO-RAD 
 
 
3.1.12 Extracts from Streptomyces spp. used in inhibitory assay 
After obtaining purified Mur ligases, the inhibitory assay was performed. In the assay 
different Streptomyces extracts were tested. Streptomyces possess strong capability of 
bioactive secondary metabolites production such as antitumoral, antifungals, anti-
hypertensives and mainly antibiotics and immunosuppressives (Maleki et al., 2013; de Lima 
Procópio et al., 2012). Streptomyces became medically important with the discovery of 
streptomycin and streptothricin. Nowadays, antibiotics produced by Streptomyces play the 
most important role in the antibiotic production. Antibiotic production is species specific 
and 80% of today used antibiotics are derived from this genus (de Lima Procópio et al., 
2012). 
 
Extracts for the inhibitory assay were provided by Christine Schorderet, BT 15, ZHAW.  
 
Code: Wurm_499_Strepto 
Label for inhibitory assay: Wurm499 
Original Code: Wurm_-4_HV_12.1.1_Strepto_V 
16S rDNA: Streptomyces europaeiscabiei 99%, Streptomyces scabiei 99%, Streptomyces 
deccanensis 99%, Streptomyces neyagawaensis 99% 
Phylogenetic: Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae; 
Streptomyces 
Remarks: sometimes inhibition of E. coli and S. aureus 
Extract: concentrated medium Gym4 (Streptomyces grow in this medium) 
 
Code: Stup17_Strepto_A52 
Label for inhibitory assay: A52 
Original Code: Stup17_A_-3_MPA_3.1.1_III 
(Continuation) 
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16S rDNA: Streptomyces gardneri 99%, Streptomyces narbonensis 99%, Streptomyces 
lateritius 99%, Streptomyces zaomyceticus 99% 
Phylogenetic: Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae; 
Streptomyces  
Remarks: pikromycin was identified 
Extract: Medium Gym 4 extracted with ethylenacetat and resuspended in methanol 
(Streptomyces grow in this medium) 
 
Code: Opok_MB_A6 
Label for inhibitory assay: A52 
Original Code: OPOK_Pj1_7_R2A 
16S rDNA: Streptomyces narbonensis 99%, Streptomyces phaeochromogenes 99%, 
Streptomyces venezuelae 99% 
Phylogenetic: Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae; 
Streptomyces  
Remarks: sometimes inhibition of E. coli and S. aureus 
Extract: concentrated medium Gym4 (Streptomyces grow in this medium) 
 
Code: Opok_MB_B11 
Label for inhibitory assay: B11 
Original Code: OPOK_Pj1_48c_R2A 
16S rDNA: Streptomyces violascens 100%, Streptomyces sp. 100% 
Phylogenetic: Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae; 
Streptomyces Remarks: actinomycin D or C2 was identified 
Extract: medium Gym 4 extracted with ethylenacetat and resuspended in methanol 
(Streptomyces grow in this medium) 
 
Code: Opok_MB_C10 
Label for inhibitory assay: C10 
Original Code: OPOK_Pj1_70_NA 
16S rDNA: Streptomyces lateritius 100%, Streptomyces phaeochromogenes 99%, 
Streptomyces sp. 99% 
Phylogenetic: Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae; 
Streptomyces 
Remarks: pikromycin was identified 
Extract: medium Gym 4 extracted with ethylenacetat and resuspended in methanol 
(Streptomyces grow in this medium) 
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3.2  METHODS 
 
3.2.1 Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) is a molecular biology technique, developed in the 1980s, 
that replicates and synthetises specific DNA segments by DNA polymerase enzymes. PCR 
reaction requires following components: DNA template, polymerase, two primers (short 
DNA fragments that determine the start of the replication), nucleotides and buffer. The result 
of the reaction is the amplification of specific DNA sequence in numerous copies. PCR 
offers a lot of benefits in molecular biology research and diagnostics. In addition, PCR plays 
a major role in the development of the gene expression study (Valones et al., 2009).  
 
3.2.1.1 DNA preparation 
 
3.2.1.1.1 Native DNA preparation 
 
DNA from eight different strains of C. difficile, obtained from CCOS, Culture Collection of 
Switzerland, was diluted 1:10, 10 μl of DNA sample and 90 μl of dH2O. No DNA isolation 
was needed to be performed. 
 
3.2.1.1.2 Synthetic DNA preparation 
 
In tubes with synthetic DNA, obtained from Thermo Fisher, 100 μl of dH2O were added and 
centrifuged for 1 minute at maximum speed. After the centrifugation, samples were 
incubated at 50°C for 10 minutes. Each minute of the incubation samples were vortexed.  
 
3.2.1.2 PCR mixture 
 
All PCR reactions in the work were performed in the volume of 40 μl. 
 
PCR mixtures contained: 
1 μl of DNA sample 
2 μl of forward primer 
2 μl of reverse primer 
20 μl of Phusion® High-Fidelity PCR Master Mix with HF Buffer* 
15 μl of dH2O 
*2x Master Mix consisting of Phusion DNA Polymerase, deoxynucleotides and reaction buffer that 
has been optimized and includes MgCl2 
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(Continued) 
3.2.1.3 PCR programme 
 
Basic PCR programme in Table 12 was used for all PCR reactions carried out in the work. 
 
Table 12: PCR programme 
Preglednica 12: PCR program 
Step Temp (ºC) Time (min) Cycle 
1 95 15:00 1 
2 94 0:30 10 
3 56 0:45 10 
4 72 01:00 10 
5 94 0:30 25 
6 56 0:45 25 
7 72 01:00 25 
8 72 07:00 1 
9 8 infinity 1 
 
3.2.1.4  Oligonucleotide primers list 
 
All oligonucleotide primers used in the work were synthetized by Microsynth, Switzerland. 
 
Table 13: List of oligonucleotide primers used in the work 
Preglednica 13: Seznam oligonukleotidnih začetnikov uporabljenih v tem delu 
TYPE OF DNA PRIMER NAME NUCLEOTIDE SEQUENCE (5’→ 3’) 
 
P_f_HIS_MurE_BamHI GCGCGCGGATCCATGCACCATCACCATCACCAATGAAATTAAA
TGATATTATACAGGGG 
 
P_f_EK_MurE_NcoI 
GCGCGCCCATGGGGCATCACCATCACCATCACGATGACAAGA
TGAAATTAAATGATATTATACAGGGG 
 
P_r_MurE_HindIII GCGCGCAAGCTTCTACATTTTACTTAAACACTCATTTG 
NATIVE 
P_r_MurE_StuI GCGCGCAGGCCTCTACATTTTACTTAAACACTCATTT 
 
P_f_HIS_MurF_BamHI 
GCGCGCGGATCCATGCACCATCACCATCACCAATGAAAGTTTT
ATTATCAGGCGGTG 
 
P_r_MurF_HindIII GCGCGCAAGCTTTTATTTATTTAGATATTCGAC 
 
P_f_HIS_MurG_BamHI 
GCGCGCGGATCCATGCACCATCACCATCACCAATGGAGTGCTT
AACAATAAAAGAG 
 
P_r_MurG_PstI GCGCGCCTGCAGTTATCTTTTCTTTATTCCTATTACC 
 
P_f_MurEs_BamHI AAATTTGGATCCATGAAACTGAACGATATTATTCA 
 
P_r_MurEs_HindIII 
GGGCCCAAGCTTTTAATGATGGTGATGATGGTGCATCTTGCTC
AGGCATTCATTTGCCACTT 
SYNTHETIC 
 
P_f_MurFs_BamHI AAATTTGGATCCATGGAATGTCTGACCATTAAAGA 
 
P_r_MurFs_HindIII 
GGGCCCAAGCTTTTAATGATGGTGATGATGGTGTTTATTCAGG
TATTCAACAATTTTTTC 
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(Continuation) 
 
Table 13: List of oligonucleotide primers used in the work 
Preglednica 13: Seznam oligonukleotidnih začetnikov uporabljenih v tem delu 
TYPE OF DNA PRIMER NAME NUCLEOTIDE SEQUENCE (5’→ 3’) 
 
P_f_MurGs_BamHI AAATTTGGATCCATGAAAGTTCTGCTGAGCGGTGG 
 
P_r_MurFs_HindIII 
GGGCCCAAGCTTTTAATGATGGTGATGATGGTGGCGTTTTTTG
ATACCAATCACTTTTGCC 
 
3.2.2 Agarose gel electrophoresis 
Agarose gel for electrophoresis was prepared as 1% agarose gel by dissolving 2 g of agarose 
standard in 200 ml of 1x TAE Buffer, heating up in microwave to dissolve all the agarose. 
Solution was cooled down a little and ethidium bromide solution was added. The gel was 
casted. DNA samples were mixed with the 5-8 μl of loading dye, depending on the volume 
of the sample and loaded on gel. Buffer used in electrophoresis cell for the run was also 1x 
TAE Buffer. Electrophoresis run on 120 V for 30 minutes. 
 
Agarose gel electrophoresis was used to confirm each step of the cloning process. 1 Kb 
Plus DNA Ladder (Carl Roth) was used as marker for electrophoretic separation.  
 
 
Figure 11: Sketch of the 1kb DNA ladder (Carl Roth, 2019) 
Slika 11: Prikaz 1kb DNK lestvice (Carl Roth, 2019)  
 
3.2.3 Extraction of DNA fragments from agarose gel 
DNA samples were extracted from agarose gel with NucleoSpin® Gel and PCR Clean-up 
kit. Kit contains Binding Buffer NTI, Wash Buffer NT3, Elution Buffer NE, NucleoSpin® 
Gel and PCR Clean-up Columns and 2 ml Collection tubes.  
 
Protocol: 
1. DNA was excised from agarose gel and its weight was determined. Gel slice was 
solubilized in Buffer NTI. For each 100 mg of agarose gel, 200 μl of Buffer NTI was 
added. Sample was incubated at 50°C for 5-10 minutes until gel was completely 
dissolved.  
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2. NucleoSpin® Gel and PCR Clean-up Columns was placed into a Collection tube and 
sample was loaded on column up to 700 μl. Everything was centrifuged for 30 s at 
11 000 x g and flow-through was discarded. Remaining sample was loaded again, 
and centrifugation step was repeated. 
3. Washing step was performed with loading of 700 μl of Buffer NT3 and afterwards 
centrifugated for 30 s at 11 000 x g.  
4. The column was centrifuged again for 1 min at 11 000 x g to completely remove 
Buffer NT3. 
5. NucleoSpin® Gel and PCR Clean-up Columns was placed into a new 1,5 ml 
microcentrifuge tube. 30 μl of Buffer NE were added, followed by 1 min incubation 
at RT and afterwards centrifugated for 1 min a 11 000 x g.  
 
3.2.4 Plasmid DNA isolation - mini preparation 
NucleoSpin® Plasmid kit is designed for rapid, small-scale preparation of highly pure 
plasmid DNA (mini prep). Kit contains Resuspension Buffer A1, Lysis Buffer A2, 
Neutralization Buffer A3, Wash Buffer AW, Was Buffer A4, Elution Buffer AE, RNase A,  
NucleoSpin® Plasmid (NoLid) Columns, Collection tubes (2 ml).  
 
Protocol for the isolation of high-copy plasmid DNA from E. coli was followed: 
1. 1-5 ml of E. coli LB culture was put in a 50 ml tube and centrifuged for 5 min at 
4500 x g. Supernatant was discarded as much as possible.  
2. Cell pellet was resuspended in 250 μl of Buffer A1 and moved to microcentrifuge 
tube. After resuspension 250 μl of Buffer A2 was added and tube was gently mixed 
by inverting 6-8 times. Tubes were incubated for 5 minutes at RT. Next, 300 μl of 
Buffer A3 was added and mixed by inverting the tube until sample turned from blue 
to colourless completely.  
3. Tubes were centrifuged for 10 minutes at 11 000 x g at room temperature.  
4. NucleoSpin® Plasmid (NoLid) Column was placed in a Collection Tube and 
supernatant from previous step was loaded up to 750 μl. After the loading, everything 
was centrifuged for 1 min at 11 000 x g. Flow-through was discarded and column 
was placed back into the collection tube. This step was repeated to load the remaining 
lysate. 
5. Buffer AW was preheated to 50°C and 500 μl of it was loaded onto the column and 
centrifuged for 1 min at 11 000 x g. Next washing step was performed with 600 μl 
of Buffer A4 and centrifuged for 1 min at 11 000 x g. flow-through was discarded. 
6. Silica membrane was dried with centrifugation for 2 min at 11 000 x g.  
7. NucleoSpin® Plasmid (NoLid) Column was placed was placed in 1,5 ml 
microcentrifuge tube and 50 μl of Buffer AE was added. Everything was incubated 
for 1 min at room temperature and centrifuged for 1 min at 11 000 x g. 
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3.2.5 Plasmid DNA isolation - maxipreparation 
Large quantities of plasmid DNA for expression experiments and eukaryotic transfection 
were isolated by PureYield™ Plasmid Maxiprep System.  
 
Procedure: 
First, the bacterial cell cultures were prepared at RT: 
1. 100 ml of transformed E. coli cells in were grown overnight 
2. The overnight culture was moved to a beak and centrifuges for 20 minutes at 4700 
rpm. The supernatant was discarded. 
3. The cell pellet was resuspended in 12 ml of Cell Resuspension Solution 
4. Cell Lysis Solution was added in the volume of 12 ml, gently mixed and incubated 
for 3 minutes at RT 
5. After the incubation, 12 ml of Neutralization Solution was added and mixed gently 
by inverting 
6. The lysate was centrifuged for 30 minutes at 7000 x g. 
 
Next, the plasmid DNA was purified at RT: 
7. Mount the blue PureYield™ closure column and the white PureYield™ binding 
column in a clearing stack. Place this column stack on the vacuum manifold 
8. A half of the lysate was poured into the blue column 
9. Vacuum was applied until the lysate passed both clearing and binding columns. 
10. The lysate left was added, and the vacuum was performed again until the liquid has 
cleared both columns. 
11. The vacuum was released, and the blue column was removed. Binding column was 
left on the vacuum manifold. 
 
Third part of the procedure was washing: 
12. 5 ml of Endotoxin Removal Wash was added to binding column, vacuum was applied 
that solution was pulled through the column. 
13. Next, 20 ml of Column Wash were added to binding column and vacuum pulled the 
solution through the column 
14. Membrane was vacuum dried for 5 minutes  
15. Binding column was removed from the vacuum manifold and places into a new 50 
ml corning tube 
 
Further, the elution by centrifugation was preformed: 
16. Binding column was put into a new 50 ml corning tube. 
17. First, 1 ml of Nuclease-Free Water was added to the binding column and centrifuged 
at 10000 x g for 1 minutes. After the centrifugation, the filtrate was harvested. 
18. Next, 500 μl of Nuclease-Free Water was added to the binding column and 
centrifuged as in previous step. The whole filtrate was collected into 1,5 ml tube. 
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At last, concentration of the sample was measured: 
Concentration was measured with NanoDrop™.  
 
3.2.6 Freezing of cell cultures 
1000 μl overnight culture was added to 500-1000 μl of glycerol pre-pipetted in cryogenic 
vials. The mixtures were vortexed and stored at -80°C. 
 
3.2.7 DNA restriction digest 
3.2.7.1 Restriction digest of mur genes 
 
Extracted product of PCR reaction was digested with two appropriate restriction enzymes 
simultaneously. Restriction digest was performed in a microcentrifuge tube.  
 
Restriction mixture was performed in total volume of 20 μl and set up of:  
10 μl of DNA sample 
l μl of each restriction enzyme 
2 μl of 10x SuRE/Cut™ Buffer B or H (10-fold) *  
6 μl of dH2O.  
*Buffer used for the digestion was chosen according to the table with percentages of activities for different 
enzymes 
Reaction mixture was incubated 1 h at 37°C. Restriction products were checked with 
agarose gel electrophoresis.  
 
3.2.7.2 Restriction digest of vector 
 
Important step for the successful cloning is the vector preparation. Inefficient digestion or 
self-ligation of plasmid DNA may result in lower cloning efficiency and in a presence of 
empty vectors. To prevent self-ligation, dephosphorylation can be carried out. Alkaline 
phosphatase performs dephosphorylation by removing the terminal 5’-phosphate group 
(ThermoFisher, 2016).  
 
Isolated plasmid DNA sample was digested with two restriction enzymes simultaneously. 
Restriction digest was performed in the mixture volume of 100 μl. 
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Restriction mixture was set up of:  
84 μl plasmid DNA 
3 μl of each restriction enzymes   
10 μl of 10x SuRE/Cut™ Buffer B or H *  
 
*Buffer used for the digestion was chosen according to the table with percentages of activities for different 
enzymes 
 
Reaction mixture was incubated for 1 h at 37°C. After the incubation, 3 μl of alkaline 
phosphatase (CIAP) were added. Restriction mixture with CIAP was incubated for further 
30 minutes on 37°C.  
Restriction products were checked with agarose gel electrophoresis.  
 
3.2.8 Ligation 
Ligation is a reaction of connecting insert DNA to a vector backbone. Ligation is performed 
with T4 DNA ligase in suitable conditions provided by buffer. ATP is required for the 
reaction. This process involves the connection of two DNA molecule ends with a 
phosphodiester bond (Padmanabhan et al., 2011).  
 
Ligation mixture was performed in total volume of 15 μl and set up of: 
1,5 of plasmid DNA 
 
11 of insert DNA 
 
1,5 of 10 x T4 DNA Ligase Buffer 
 
1,0 T4 DNA Ligase  
 
Ligation programme was composed of three steps: (1) 6 hours’ incubation at 16°C, (2) 12 
hours incubation at 8°C and (3) 10 minutes incubation at 70°C to inactivate T4 DNA Ligase.  
Figure 12: Alkaline phosphatase mechanism of action - dephosphorylation (Thermo Fisher, 2019a) 
Slika 12: Akcijski mehanizem alkalne fosfataze - defosforilacija (Thermo Fisher, 2019a) 
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3.2.9 Measuring DNA/protein concentrations with NanoDrop™ 
DNA and protein concentrations were measured with NanoDrop™ system. After the 
selection of the type of sample measured, 2 μl of a sample was pipetted on the pedestal. The 
optical density is measured at different wavelengths - for the proteins at 280 nm and for the 
nucleic acids at 260 nm.  
 
3.2.10 Transformation   
After the ligation, the recombinant plasmid, as product of the ligation reaction, is 
transformed into bacteria. The transformed bacteria are selected by growth on agar, whether 
they have the plasmid of interest. Single colonies are selected and tested for the presence of 
insert. The transformation can be achieved by chemical method or electroporation 
(Padamanabhan et al., 2011).  
 
3.2.10.1 E. coli Top10/NEB® 10-beta competent cells 
 
Transformation into E. coli Top10 or NEB® 10-beta Competent E. coli (High Efficiency), 
derivates of DH10B, was performed after the ligation reaction. The strains are appropriate 
for cloning and plasmid propagation. They allow stable replication of high-copy number 
plasmids.  
 
Procedure: 
1. Competent cells were moved from -80°C on ice. After the cells were thawed, all 
ligation mixture was added to the tube with competent cells.  
2. Tube was mixed gently and incubated on ice for 5 minutes.  
3. After the incubation, cells were heat shocked on 42°C for 30 seconds and 
immediately put on ice for 5 minutes.  
4. Next, the 250 μl of SOC medium was added to the tube.  
5. Mixture was then incubated on 37°C for 1 hour with slightly shaking.  
6. After the incubation, sample was spread on the plates. Sample from each tube was 
spread onto two plates, on first was put 100 μl of sample and on second the rest of 
the mixture. Selection of plates depends on the vector used for ligation: 
a. LB + kanamycin plates were used for the ligation mixtures with pPET28a   
b. LB + Ampicillin plates were used for the ligation mixtures with pSIL  
7. Plates were incubated overnight at 37°C. 
 
 
3.2.10.2 BL21 and BL21-CodonPlus (DE3) E. coli competent cells 
 
BL21 strain is the most common used strain for the protein expression. The BL21-
CodonPlus cells increase protein expression in E. coli by resolving problem of codon bias. 
The expression plasmid extracted by plasmid miniprep was transformed into cloning hosts 
BL21 or BL21-CodonPlus cells. 
   
Pušić M. Detection of potential actinobacterial inhibitors of bacterium Clostridium difficile Mur ligases. 44 
   M.Sc. Thesis (Du2). Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2019 
  
 
Procedure: 
1. Competent cells BL21 were moved from -80°C on ice. After cells were thawed, 1,0 
μl of DNA (plasmid + insert) was added to the tube with competent cells.  
2. Tube was mixed gently and incubated on ice for 5 minutes.  
3. After the incubation, cells were heat shocked on 42°C for 10 seconds and 
immediately put on ice for 5 minutes.  
4. Next, the 250 μl room temperature SOC medium were added to the tube.  
5. Mixture was then incubated on 37°C for 1 hour with slightly shaking.  
6. After the incubation, sample was spread on the plates LB with kanamycin and 
chloramphenicol. Sample from each tube was spread onto two plates, on first was 
put 100 μl of sample and on second the rest of the mixture. 
7. Plates were incubated overnight at 37°C.  
 
3.2.10.3 DH10Bac™ Competent Cells 
 
DH10Bac™ competent cells are used to produce recombinant baculoviral molecules for the 
high-level expression of recombinant proteins. The baculoviral DNA may be isolated and 
transfected into insect cells.  
 
Procedure: 
1. Competent cells were moved from -80°C on ice. After cells were thawed, 1,0 μl of 
plasmid DNA with gene of interest was added to the tube with competent cells.  
2. Tube was mixed gently and incubated on ice for 5 minutes.  
3. After the incubation, cells were heat shocked on 42°C for 45 seconds and 
immediately put on ice for 2 minutes. 
4. Next, the 250 μl of room temperature SOC medium were added to the tube.  
5. Mixture was then incubated on 37°C for 4 hours at 225 rpm.  
6. After the incubation, sample was spread on the LB agar plates containing 50 μg/ml 
of kanamycin, 7 μg/ml of gentamicin, 10 μg/ml of tetracycline, 100 μg/ml of X-gal, 
and 40 μg/ml of IPTG. Sample from each tube was spread onto two plates, on first 
100 μl of sample were spread and on second the rest.  
7. Plates were incubated for 48 hours at 37°C.  
 
Insertions of the mini-Tn7 into the mini-attTn7 attachment site on the bacmid disrupt the 
expression of the LacZα peptide, so colonies containing the recombinant bacmid were white 
in a background of blue colonies. Therefore, the big white colonies were selected for the 
further analysis. 
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3.2.11 Confirmation of positive clones with plasmid digestion 
Successful cloning was confirmed with plasmid digestion of clones. After the transformation 
to competent cells, colonies were picked and used for the inoculation of the corresponding 
media, depending on the vector used for the cloning procedure. After the overnight 
incubation, samples were purified with NucleoSpin® Plasmid. Purified plasmid DNA was 
digested with the same restriction enzymes used for the preparation of insert and vector for 
the cloning. 
 
All plasmid digestion procedures in this work were performed as the same mixture in the 
volume of 20 μl, containing: 
4 μl of plasmid DNA 
 
2 μl of buffer B or H 
 
1 μl of each restriction enzyme  
 
11 μl of dH2O 
Mixture was incubated on 37°C for 30 min. After the incubation, agarose gel 
electrophoresis was performed to show results of the digestion. 
 
3.2.12 E. coli protein expression 
Overnight pre-culture was prepared in 10 ml of LB liquid medium supplemented with 
kanamycin and inoculated with a small amount of cells from glycerol stock. Preculture was 
incubated at 37°C overnight in a shaker. Next day, 100 ml of LB liquid medium was 
inoculated with 2 ml of overnight preculture. Then, the culture was incubated in a shaking 
incubator at 250 rpm and 37°C until optical density at 600 nm (OD600) reached around 0,6. 
At that point, the cultures were induced with 1 ml of 1 mM IPTG and incubated again either 
on 37°C or 20°C with shaking. Samples were obtained every hour for the four hours after 
the induction and the last one was obtained after the overnight incubation. Each sample was 
used for measurement of optical density with spectrophotometer and for the SDS-PAGE 
analysis. Volume of the sample for density measurement was 1 ml, volume for SDS-PAGE 
analysis was calculated according to wanted OD600=1.8 of the sample. Samples for SDS-
PAGE were harvested at 4°C until the analysis. 
 
Overnight expression culture was centrifuged for 10 minutes at 4700 rpm at 4°C. The 
supernatant sample was obtained for the analysis. Cell pellets were collected as well and 
used for protein purification. 
 
3.2.13 SDS-page analysis 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-page) is a technique 
used for the determination and separation of proteins based on their molecular weight (Rath 
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et al., 2008). SDS is a detergent involved in destruction of the tertiary structure of the protein 
as linear molecule is required for the analysis. It gives the protein a negative charge needed 
to through polyacrylamide gel matrix. Gel was sustained from two parts, stacking and 
running, both compositions are described in Table 6. 
 
All the SDS-page analyses performed in this work were carried out with 12% SDS 
polyacrylamide separating gel. 
 
Procedure: 
1. Gel-casting system was assembled. Running gel was prepared first and transferred 
onto system. After the polymerization of the running gel, stacking gel was prepared 
and loaded onto running gel.  
2. Expression samples were centrifuged for 5 min at 11 000 rpm and supernatant was 
discarded.  
3. Samples were added 20 μl of Laemmli buffer Roti®-Load 1 and denatured with 
incubation at 95°C for 10 minutes.  
4. After denaturation samples were centrifuged at 11 000 rpm for 2 minutes.  
5. 15 μl of each sample and 5 μl of marker were loaded on gel. 
6. SDS-page run constantly on 180 V for 45 minutes in 1x TGS buffer.  
 
Proteins loaded on the gel had a negative charge as they were denatured, and they moved to 
the positive electrode. At the end of the electrophoretic separation, the results were analysed 
with Coomassie staining.  
 
7. Gel was stained with Coomassie Brilliant Blue R-250 for 45 minutes.  
8. In order to see the proteins, gel was destained with destaining solution composed of 
50% dH20, 40% NaOH, 10% acidic acid.  
 
Marker used for protein identification and for the molecular weight confirmation was 
Precision Plus Protein™ Dual Color Standard, ranging from 10 to 250 kDa. 
Figure 13: Marker ladder used for SDS-page analysis (BioRad, 2019) 
Slika 13: Lestvica uporabljena za SDS-page analizo (BioRad, 2019) 
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Gel, as result of electrophoresis, without Coomassie staining, could be used for Western blot 
analysis.  
 
3.2.14 Western blot 
Western blot is an important technique commonly used in research for separation and 
identification of proteins. Proteins separated on electrophoresis gel are transferred to a 
membrane. The membrane is incubated with antibodies targeted to the protein analysed. 
Antibodies should only bind to one protein and the thickness of the band corresponds to the 
amount of protein presented (Mahmood and Yang, 2012).  
 
Procedure: 
1. Gel with samples was prepared with SDS-page electrophoresis. 
2. The membrane was placed between gel surface and the positive electrode in a 
sandwich. Sandwich consisted a sponge at each end and two blotting filter papers to 
protect the gel and blotting membrane.  
3. Gel sandwich was put in the blotting chamber. 
4. Blotting chamber was placed in the blotting module, which was filled with 1x Western 
blot running buffer. Next to the blotting chamber, the ice box was added to the blotting 
module preventing high temperatures, which could destroy the transfer.  
5. Blotting was done in at 230 mA for 1,5 h.  
6. Proteins from the gel were transferred to a membrane. The transfer was done using an 
electric field oriented perpendicular to the surface of the gel, causing transfer of 
proteins on the membrane.  
 
Immunodetection with antibodies: 
7. Next step was blocking of the membrane. It prevents non-specifically binding of anti-
His antibodies. Blocking solution was 3% BSA (0,6 g of BSA) diluted in 20 ml of 
TBS. Membrane was blocked in blocking solution for 30 minutes on shaker at RT. 
8. After the blocking, primary antibody solution was added, and membrane was 
incubated with shaking for 1 hour at room temperature (RT) or overnight in cold 
room.  
9. Primary antibodies were removed, and membrane was washed. For washing 20 ml of 
PBS was put on the membrane and incubated for 5 minutes with shaking at RT. After 
5 minutes, PBS was removed. The washing step was repeated three times.  
10. After the washing, the secondary antibodies solution was added. Incubation took 2 
hours with shaking on RT.  
11. After incubation the same washing step was performed as described in Step 9.  
12. Final step was the detection. For the detection membrane was prepared with West 
Dura Kit for measurement with ImageQuant LAS 500 CCD imager.  
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3.2.15 Concentration and filtration of the protein with Amicon® Centrifugal Filters 
Amicon® centrifugal filters are used to concentrate and desalt column fractions from protein 
purification processes.  
 
Procedure: 
1. The sample was added to the reservoir of the centrifugal device. 
2. The sample was centrifuged at 4500 rpm at 4°C until it was concentrated to 250-500 
μl. 
3. The concentrate sample was moved to a microcentrifuge tube. 
4. The sample concentration was measured. 
 
3.2.16 Isolation of bacmid DNA 
Recombinant bacmid DNA was generated as pFastBac™ plasmid containing gene of interest 
and the construct was transformed into DH10Bac™ cells. Between transposon element on 
pFastBac™ and the target site on the bacmid transposition occurred (Invitrogen).  
 
Procedure: 
1. White single white colonies were picked from LB plates containing 50µg/mL 
kanamycin, 7 µg/ml gentamicin and 10 µg/ml tetracycline and inoculated the same 
LB liquid medium.  
2. The culture was grown overnight on 37°C.  
3. Next day, 1,5 ml of the overnight culture was transferred to 1,5 ml Eppendorf tube 
and centrifuged at 14 000 x g for 1 minute.  
4. Supernatant was removed and cell pellet was resuspended in 0,3 ml of Solution I.  
5. 0,3 ml of Solution II was added, mixed gently and incubated at RT for 5 minutes.  
6. After the incubation, 0,3 ml of 3 M potassium acetate [pH 5.5] was added. A white 
precipitate of E. coli protein and genomic DNA was formed.  
7. Mixture was incubated on ice for 10 minutes and then centrifuged at 14 000 x g for 
10 minutes.  
8. Supernatant was transferred to Eppendorf tube containing 0,8 ml of isopropanol. The 
tube was inverted several times and placed on ice for 10 minutes.  
9. After the incubation on ice, centrifugation was done at 14 000 x g for 15 minutes at 
RT.  
10. Supernatant was removed, and 0,5 ml of 70% ethanol was added.  
11. Tube was inverted several times for pellet to be washed and then centrifuged for 5 
minutes at 14 000 x g at RT. Supernatant was removed as much as possible.  
12. Pellet was air dried for 5-10 minutes and after dissolved in 40 μl of TE buffer [pH 
8.0].  
13. Isolated bacmid DNA was stored at 4°C.  
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3.2.17 Transfection of insect cells 
First step of baculovirus mediated insect cell expression is transfection of recombinant 
bacmid DNA into insect cells.  
 
Sf-9 insect cells were grown in Sf-900™ II SFM (1X) medium at 27°C with shaking.  
 
Procedure: 
1. Number of insect cells was measured with NucleoCounter®. Sample was taken from 
liquid culture to Eppendorf tube and loaded onto cassette. Properly loaded cassette 
was loaded into the NucleoCounter® instrument for the measurement and software 
analysis of the cells. The goal was to have approximately 1 million cells in 2 ml in 
each well.  
Further work was performed in the sterile environment in the incubator with flow. 
2. Culture was diluted according to the total number of the cells. 
3. 2 ml of insect cell culture was pipetted into each well of a 6-well-microwell plate and 
incubated for 1 h to attach the bottom. 
4. Meanwhile, the DNA samples were prepared.  
a. In 15 ml falcon tube master mix containing Sf-900™ II SFM (1X) medium 
and Plus™ Reagent (a reagent for pre-complexing DNA that enhances 
cationic lipid-mediated transfection of DNA into cultured eukaryotic cells) 
was prepared and incubated for 10 minutes). 
b. In second 15 ml falcon tube master mix containing Sf-900™ II SFM (1X) 
medium and CellFectin™ II reagent (allowing optimal transfection) was 
prepared and incubated for 30 minutes. 
c. DNA samples were pipetted into sterile Eppendorf tubes. Volume was 
appropriately calculated to wanted 4 μg of DNA. 
d. Into each tube with DNA, the Plus™ Reagent and CellFectin™ II reagent 
was added, respectively. 
e. Tubes were incubated for 30 minutes. 
5. The binding of the cells to surface was checked under the microscope. 
6. Mixtures with DNA were plated in the wells. 
7. Plates were incubated on 27°C in the incubator.  
8. The next day, the media was changed, and the cells were checked under the 
microscope if they were potentially detached. (Dying cells start to detach from 
surface and they get bigger. If the number of the cells is the same after 3 days, means 
virus is starting to be produced.) 
9. After three days the cells were checked again under the microscope.  
a. Native DNA: RFP was used as marker and it allowed screening of successful 
transfection  
b. Synthetic DNA: no marker was provided 
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10. As RPF production had peaked, SDS-page and Western blot analysis was performed 
to check if Mur proteins were synthetized. Synthetic bacmid DNA did not have a 
marker, so SDS-page and Western blot analysis were performed on time course.  
11. Cells were harvested. 
 
3.2.18 Immobilized metal-affinity chromatography  
Immobilized metal-affinity chromatography (IMAC) is a powerful and widely used 
purification method (Maunsell, 2000). The method is based on the interaction between Ni2+ 
metal ion on the matrix and amino acid histidine on our protein of interest. Purification was 
performed with ÄKTA protein purification system.  
 
Procedure: 
1. Protease inhibitor and lysozyme were added to the sample and it was incubated 
for 30 minutes. 
2. UNICORN software was launched.  
3. Superloop was assembled and two column holders were attached to the column 
holder rail. The column was mounted on the column holders 
4. Inlet A1 was placed in water and inlet B into elution buffer. Waste bottle was 
placed beside the instrument. System was washed with water for 5 minutes.  
5. After washing of the column with the water was performed, calibration with 
binding buffer followed. Inlet A1 was put in binding buffer. The flow was set to 
1 ml/min for 7 minutes.  
6. Sample was lysed by sonication on ice. Sonication was performed in 5 cycles. 
Each cycle had two steps: first 30 seconds of sonication and then 30 seconds of 
standing. Sonication was performed on ice and with 30 seconds of break because 
the sonication process increases temperature and high temperature could lead to 
denaturation of the sample. 
7. After the sonication, the sample was centrifuged for 10 minutes at 4700 rpm.  
8. Approximately 50 ml of supernatant was loaded on the column with syringe.  
9. His superloop 50ml purification program was run for the elution of the protein. 
10. Program collected fractions in the volume of 1 ml for each step of the purification. 
As well, the waste was collected.  
11. According to the chromatogram, fractions were selected for SDS-page and 
Western blot analysis.  
12. At last, the clean-up of the system was performed with water and 20% ethanol.  
 
3.2.19 Size exclusion chromatography 
Size exclusion chromatography (SEC) also called gel filtration separates molecules by 
differences in their size as they pass through a resin packet in a column. As molecules do 
not interact with chromatography resin, buffer does not directly affect resolution (GE 
Healthcare, 2001). SEC was performed with ÄKTA system and UNICORN software. 
Samples used for SEC was concentrated using centrifugal filters. 
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Procedure: 
1. The system was prepared. Gel filtration buffer was prepared and Superdex 200 
column was connected to the system.  
2. Column was first washed with water. Inlet A1 was put in the water and washing was 
performed at flowrate 0,50 ml/min. 
 
Maximum pressure in the column was 1,5 kPa. If pressure was above that value, the flowrate 
was reduced. 
 
3. After the washing the waste tubing was prepared and inlet A was immersed in the 
bottle containing the buffer. 
4. 500 μl of sample with the protein of interest was loaded in the loop with the syringe 
and the program Gelfiltration mit Superdex 200 Loop 500 μl was chosen. Flowrate 
was 0,40 ml/min. 
5. Program collected fractions in the volume of 1 ml for each step of the purification. 
As well, the waste was collected.  
6. Based on the chromatogram, fractions were selected for SDS-page and Western blot 
analysis. 
7. System was cleaned with water and 20% ethanol. 
 
3.2.20 Inhibitory activity assay 
Inhibitory activity assay was performed with ProFoldin kits. ProFoldin manual had been 
followed (described in Section 3.2.20.1). The bacterial MurE and MurD assays are based on 
measurement of the inorganic phosphate generated from the MurE and MurD reaction. The 
inorganic phosphate is detected by light absorbance at 650 nm. 384-well or 96-well assay 
plates are used for the assay performance. Alternatively, the assay reaction can be performed 
in Eppendorf tubes and the signal is measured using a cuvette. The high throughput assay 
can be used for screening inhibitors of bacterial MurE and MurD in drug discovery research. 
It may also be used for characterization of bacterial MurE and MurD. 
 
3.2.20.1 Protocol 
 
Reaction was performed in 96-well plate. Reaction volume was 60 μl and the final assay 
volume was 150 μl. 
 
Procedure: 
1. Reagent was prepared for 10 assay reactions. 
a. Premix I: Total volume of premix was 297 μl.  
 261 μl of H2O, 33 μl of 10x Buffer and 3,3 μl of 100x E. coli MurE 
 261 μl of H2O, 33 μl of 10x Buffer and 3,3 μl of 100x S. aureus 
MurD 
b. Premix II: Total volume of premix II was 297 
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  231 μl of H2O, 33 μl of 10 x Buffer and 33 μl of 100 x purified and 
concentrated MurE 
  261 μl of H2O, 33 μl of 10 x Buffer and 3,3 μl of 100 x purified and 
concentrated MurD 
2. 10 x Enzyme substrate for MurD assay was prepared by mixing 3,3 μl of 100 x 
UMA, 3,3 μl of 100 x D-Glu, 3,3 μl of 100 x ATP and 23,1 μl of water.  
3. 10 x Enzyme substrate for MurE assay was prepared by mixing 3,3 μl of 100 x 
UMAG, 3,3 μl of 100 x DAP, 3,3 μl of 100 x ATP and 23,1 μl of water. 
4. In each well 27 μl of the premix I or II was mixed with 3 μl of the 10 x Enzyme 
substrate for each protein. The reaction mixture for MurD was incubated at RT for 
60 min. The reaction mixture for MurE was incubated at 37°C for 60 min.  
5. After the incubation, detection was performed. Into each well with the reaction 
mixture, 45 μl of the Dye MPA3000 were added and incubated for 5 minutes.  
6. Light absorbance was measured at 650 nm 
 
3.2.20.2 Inhibition of fosphomycin and negative controls, HCl and MeOH 
 
First, the fosphomycin (PM), positive (PC) and negative controls (NC) were tested. Negative 
controls were HCl and methanol (MeOH). HCl was tested as it was presented in elution 
buffer used in the size exclusion chromatography procedure. Methanol was tested because 
extracts tested for the inhibitory activity were stored in it.  
 
1. 3 ml of 1 M HCl was prepared from 1.2 M HCl by mixing 2.5 ml of 1,2 M HCl and 
0,5 ml of H2O. 
2. 1 ml of methanol was used for the reaction. 
3. Fosphomycin was prepared in the concentration of 5 mM in 1 ml.  
4. Premix was prepared four times in double volumes as described in protocol above.  
5. Assay was performed in 96-well plate. 
6. Each component of the test was plated into 2 wells: 
a. Positive control - enzyme from the kit: 2 x 27 μl of premix 
b. Fosphomycin: 2 x 26,4 μl of premix and 2 x 0,6 μl of fosphomycin 
c. Negative control (HCl): 2 x 26,4 μl of premix and 2 x 0,6 μl of HCl 
d. Negative control (MeOH): 2 x 26,4 μl of premix and 2 x 0,6 μl of MeOH 
7. Everything was incubated 5 min on RT.  
8. 3 μl of substrate was added into each well and incubated for 1 h 
9. After the incubation, detection was performed. 45 μl of the Dye MPA 300 was added 
into each well and incubated for 5 minutes.  
10. Light absorbance was measured at 650 nm.  
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3.3 PLAN OF THE EXPERIMENT 
 
The experiment was divided into two parts:  
1. work with native, wild-type DNA of C. difficile, using eight different strains, 
obtained from CCOS, Culture Collection of Switzerland; 
2. work with synthetic DNA of C. difficile synthetized by Invitrogen, Thermo Fischer 
Scientific.  
 
For the analysis of Mur ligases from native DNA of C. difficile MurC and MurE ligase were 
chosen. For the analysis of Mur ligases from synthetic DNA, MurE, MurF and MurG were 
selected.  
 
Mur ligases from both types of the DNA were used for recombinant protein expression in 
two different protein expression systems: 
1. expression in E. coli 
2. expression in insect cells 
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3.3.1 The flow of the experiments with native DNA 
 
C. difficile 
NATIVE DNA
Expression system:
E. coli
PCR with 8 different C. difficile strains, gel 
electrophoresis, NucleoSpin® Gel and PCR Clean Up
Restriction digest of insert 
and plasmid DNA
Ligation
Transformation in 10-beta E. coli competent 
cells + plating on LB + Kan
Inoculation of 5 ml of LB+Kan with 
transformant colonies 
NucleoSpin® 
Plasmid clean up
Plasmid restriction and gel 
electrophoresis
Transformation of plasmid with Mur insert in BL21 
(DE3) Competent cells + plating on LB+kan+cam
Inoculation of 5 ml LB+kan+cam 
with single colonies
NucleoSpin® Plasmid clean up
Plasmid restriction and gel 
electrophoresis
Recombinant protein expression at 
20°C and 37°C
SDS-page and 
Western blot
Results
Expression system:
Insect cell
PCR with 8 different C. difficile strains, gel 
electrophoresis, NucleoSpin® and PCR Clean up
Restriction digest of insert 
and plasmid DNA
Ligation
Transformation in 10-beta E. coli 
competent cells + plating on LB + Amp
Inoculation of 5 ml of LB+Amp with 
transformant colonies 
NucleoSpin® Plasmid clean up
Plasmid restriction and gel 
electrophoresis
Transformation of plasmid with Mur insert in 
DH10 Bac Competent cells + plating on 
LB+kan+tet+gen
Inoculation of 5 ml LB+kan+tet+gen with 
single white colonies
Bacmid DNA isolation
Control for inserts with PCR
Measurment of bacmid DNA 
concentrations
Transfection of insect cells
Flourescent microsopy for the detection 
of RFP
SDS-page and Western blot
Results
Figure 14: Diagram of the flow of the experiments with native DNA of C. difficile 
Slika 14: Prikaz poteka eksperimentov z nativno DNA C. difficile  
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3.3.2 The flow of the experiments with synthetic DNA 
C. difficile 
SYNTHETIC DNA
Expression system:
E. coli
PCR, gel electrophoresis
Restriction digest of insert and 
plasmid DNA
Ligation
Transformation in Top10 E. coli competent 
cells + plating on LB + Kan
Inoculation of 5 ml of LB+Amp with 
transformanl colonies 
NucleoSpin® Plasmid clean up
Plasmid restriction and gel electrophoresis
Transformation of plasmid with Mur insert in BL21 
Competent cells + plating on LB + kan 
Inoculation of 5 ml LB+kan with single  
colonies
NucleoSpin® Plasmid clean up
Plasmid restriction and gel 
electrophoresis
Recombinant protein 
expression at 20°C 
SDS-page and Western blot
ÄKTA protein purification
SDS-page and Western blot
AMICON centrifugation
Size exclusion chromatography
SDS-page and Western blot
AMICON centrifugation
SDS-page and Western 
blot
Enzyme inhibitory assay
Results
Expression system:
Insect cell
PCR, gel electrophoresis
Transformation of plasmid with Mur insert in DH10 
Bac™ Competent cells + plating on LB+kan+tet+gen
Inoculation of 5 ml LB+kan+tet+gen with 
single white colonies
Bacmid DNA isolation
Measurment of bacmid DNA concentrations
Transfection of insect cells
SDS-page and Western 
blot
Results
Figure 15:  Diagram of the flow of the experiments with synthetic DNA of C. difficile 
Slika 15: Prikaz poteka eksperimentov s sintetično DNA C. difficile 
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4 RESULTS 
 
4.1 NATIVE DNA OF C. difficile 
 
MurC and MurE proteins were selected for the work with native DNA of C. difficile. Size 
of murC gene is 1482 bp and murE 1296 bp. 
 
4.1.1 Expression system: E. coli 
 
4.1.1.1 Polymerase chain reaction 
 
Polymerase chain reaction (PCR) using appropriate primers (Table 13) was performed to 
amplify the murC and murE genes. These two genes of interest were amplified from C. 
difficile chromosome (strains CCOS-938 and CCOS-871). Agarose gel electrophoresis was 
used to confirm the results of PCR. Figure 16 shows that murE was successfully amplified 
from CCOS-938, however not from CCOS-871. The right opposite situation was shown with 
murC, which was successfully amplified from CCOS-871 and not from CCOS-938. Both 
PCR products were extracted from agarose gel using NucleoSpin® Gel and PCR Clean-up 
kit and positively verified by DNA sequencing.  
Figure 16: Agarose gel electrophoresis of PCR amplification of murC and murE genes 
Figure 16.A shows results with CCOS-938 strain. Lanes: M- marker - 1 kb molecular weight 
standard, 1, 2 - murC; 3,4 - murE. Figure 16.B shows PCR results with strain CCOS-871. 
Lanes: M-marker - 1 kb molecular weight standard, 1,2 - murC; 3,4 - murE. 
Slika 16: Agarozna gelska elektroforeza murC in murE PCR pridelkov. 
Slika 16.A prikazuje rezultate s sevom CCOS-938. Linije: M-marker-1kb standard; 1,2 - murC; 
3,4 - murE. Slika 16.B prikazuje rezultate s sevom CCOS-871. Linije: M-marker-1kb standard; 
1,2 - murC; 3,4 - murE 
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4.1.1.2 Restriction digestion 
 
Restriction digestion is commonly used in molecular cloning of insert into a vector. Vector 
usually contains a multiple cloning site, where many restriction sites are found (Hartl and 
Jones, 2001).  
 
Digestion was performed to prepare insert and vector for cloning procedure. Several 
restriction enzymes were used for cleaving DNA of murC and murE at their specific 
restriction sites. Both the insert and the vector pPET28a were cut with the same enzymes. 
After the digest reaction, restriction fragments were analysed with agarose gel 
electrophoresis.  
 
The enzymes NdeI and XhoI successfully digested murC as shown in Figure 17, line 1. 
Restriction of murE was more complicated as several restriction enzymes also had their 
restriction sites on the insert. Restriction enzymes combinations of NdeI and HindIII (Figure 
17, line 2) and NcoI and StuI (Figure 17, line 3) were not successful. Restriction was 
successfully performed with NcoI and HindIII (Figure 17, lines 4 and 5). 
 
DNA products were extracted from agarose gel with NucleoSpin® Gel and PCR Clean-up 
kit. Digested pET28a and murC and murE gene fragments were ligated with T4DNA ligase. 
Figure 17: Restriction digestion of murC and murE 
Lines: M-marker - 1kb molecular weight standard; 1-restriction digest of murC, 2-5 - 
restriction digest of murE with different restriction enzymes; 6-restriction digestion of pPET28a 
Slika 17: Restrikcija genov murC in murE 
Linije: M-marker - 1kb molekulski standard; 1-restrikcija murC gena; 2-5 - restrikcije gena murE z 
različnimi restrikcijskimi encimi; 6 - restrikcija pPET28a 
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4.1.1.3 Plasmid digestion after transformation of murC and murE to Top10 E. coli competent 
cells 
 
Ligation products were transformed into Top10 E. coli competent cells. Screening for the 
positive colonies that contained constructs pET28a::murC and pET28a::murE was 
performed with plasmid digestion with the same restriction enzymes that were used for the 
preparation for the cloning procedure. Agarose gel electrophoresis was used to identify 
positive clones. Figure 18.A shows the results of digestion of murC clones. Samples in lanes 
6 and 7 had the right insert size and were selected for the further work. Figure 18.B shows 
the results of digestion of murE. Clones in all lines had the correct insert with expected size. 
Clones market in Figure 18 were used for further work. 
 
Positive clones containing pPET28a::murC and pPET28a::murE were double checked by 
sequencing.  
 
 
 
 
 
Figure 18: Confirmation of successful transformation of plasmid with murC and murE inserts into 
Top10 E. coli competent cells with plasmid digestion 
Lane M on both sides is the marker, 1 kb molecular weight standard. Figure 18.A: Lanes 1-8 are 
samples with pPET28a::murC. Figure 18.B: Lanes 1-8 are samples with pPET28a::murE. Clones 
marked in both pictures were used for further work (murC, lines 6-7; murE, lines 5-8) 
Slika 18: Potrditev uspešne transformacije plazmidov z insertoma murC in murE v Top10 E. coli kompetentne 
celice z restrikcijo plazmidov 
Linija M je na obeh straneh marker, 1kb molekulski standard. Slika 18.A: Linije 1-8 so vzorci z 
pET28a::murC. Slika 18.B: Linije 1-8 so vzorci z pET28a::murE. Kloni, ki so označeni na obeh slikah, so bili 
uporabljeni za nadaljnje delo (murC, liniji 6-7; murE, linije 5-8) 
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4.1.1.4 Plasmid digestion after transformation to BL21-CodonPlus (DE3) competent cells 
 
Double positive clones were then transformed into chemically competent BL21-CodonPlus 
(DE3) E. coli cells, which are suitable for high level protein expression. What is more, 
CodonPlus competent cells are used for the expression of proteins that are difficult to express 
in due to their codon usage. They provide additional copies of tRNA genes that are rare to 
E. coli. Target genes were cloned in expression vector to produce the proteins, using IPTG 
as an inducer.  
 
Figure 19 shows results of an identification of the presence of positive clones in BL21-
CodonPlus (DE3) strain performed with plasmid digestion. In Figure 19.A two bands can be 
seen, one from pPET28a plasmid and the other from CodonPlus plasmid. Clearly, one of the 
enzymes did not cut well as one can see the insert was missing, probably due to methylation 
in the restriction site. Methylation sites can overlap with restriction sites and consequently 
inhibit enzymes. Further screening for the confirmation of murC clones was successfully 
performed with PCR amplification (picture not provided). Figure 19.B represents results of 
PCR amplification of murE and a positive result was obtained for all eight probes.  
 
 
 
 
 
 
Figure 19: Confirmation of successful transformation of pPET28a with murC and murE into BL21-CodonPlus 
competent cells 
Lane M on both sides is the marker, 1 kb molecular weight standard. Figure 19.A: lines 1-8 are clones with murC 
as insert. Figure 19.B: lines 1-8 are clones with murE as insert confirmed with PCR amplification. 
Slika 19: Potrditev uspešne transformacije pPET28a z murC in murE v BL21-CodonPlus kompetentne celice 
Linija M je na obeh straneh marker, 1 kb molekulski standard. Slika 19.A: Linije 1-8 so kloni z insertom murC. Slika 
19.B: Linije 1-8 so kloni z insertom murE, potrjeni z PCR reakcijo. 
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4.1.1.5  Expression of MurC and MurE 
 
Following the transformation of pPET28a::murC and pPET28a::murE into BL21-CodonPlus 
(DE3) competent cells, positive clone of each was chosen for protein expression at 20°C and 
37°C. Lower temperature was used as well, because many recombinant proteins often 
precipitate at 37 °C but are soluble when the temperature during induction is 15–25 °C, 
probably due to slower protein production rates allow proper protein folding (Gräslund et 
al., 2008).  
 
During the expression samples were obtained to follow the course of the expression. First 
sample was obtained at induction with IPTG (time: 0h). Next three samples were taken for 
3 hours after the induction (time: 1h, 2h, 3h) and the last one after overnight incubation. OD 
of each sample was measured with spectrophotometer. OD600 is estimation of the 
concentration of bacterial cells in expression culture. Figure 20 shows very similar growth 
rate of both expression cultures in first hour of the growth. Afterwards, small differences 
start to show. MurE expression culture at 37°C and MurC expression culture at 20°C 
performed higher growth in comparison to MurC expression culture at 37°C and MurE 
expression culture at 20°C. Significant decrease of E. coli growth was shown after overnight 
incubation of the culture with MurE (37°C) and MurC (20°C) expression cultures. This 
growth reduction was probably due to toxicity of proteins expressed at unfavourable 
conditions.  
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Growth rates of E. coli during the expression of MurC and MurE at 20°C 
and 37°C 
Slika 20: Vrednosti rasti E. coli med izražanjem MurC in MurE pri 20 °C in 37 °C 
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SDS-page and Western blot analysis were performed with both proteins of interest, including 
MurD. MurD was used as positive control of the whole process. Construct pPET28a::murD 
was provided by David Frasson, ZHAW Life Sciences und Facility Management, 
Department of Molecular Biology and it was synthetically codon optimized for expression 
in E. coli and insect cells. 
 
Judged by SDS page analysis (Figure 21 and 22) there was no protein expression either for 
MurC or MurE. Further investigation was performed with Western blot. Immunodetection 
with anti-His antibodies showed the same result as SDS-page for both proteins.  
 
At the same time, expression was performed for positive control MurD, to show the proof 
of concept and to perform the reagents control. MurD had already shown positive result on 
SDS-page and as well with Western blot analysis (Figures 21 and 22). 
 
MurC and MurD - 20°C 
The molecular weight of MurC is 48,2 kDa. In Figure 21.A SDS-page analysis did not 
show positive result of the expression, which was also confirmed with Western blot 
(Figure 21.B). On the other hand, MurD (49,5 kDa) was positively expressed and 
confirmed by both, SDS-page and Western blot analyses (Figure 21). 
 
 
 
 
 
 
Figure 21: SDS-page and Western blot analysis of MurC and MurD protein expression at 20°C 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Figure 21.A - SDS-page 
analysis of MurC protein expression and MurD expression as positive control. Figure 21.B - Western 
blot analysis of MurC protein expression and MurD expression as positive control.  
Slika 21: SDS-page in Western blot analiza izražanja proteinov MurC in MurD pri 20 °C 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Slika 21.A - SDS-page analiza izražanja 
proteina MurC in proteina MurD, ki predstavlja pozitivno kontrolo. Slika 21.B - Western blot analiza 
izražanja proteina MurE in proteina MurD, ki predstavlja pozitivno kontrolo. 
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MurC and MurD - 37°C 
 
Experiment was repeated with changed expression conditions. Temperature of incubation 
was increased to 37°C. Figure 22 shows that E. coli did not express recombinant MurC, 
amplified from C. difficile at 37°C. In comparison, MurD showed positive protein expression 
confirmed by both, SDS-page and Western blot analysis.  
 
MurE - 20°C and 37°C 
 
Figure 23 shows the results of MurE protein expression at both temperatures studied. Either 
on 20°C or on 37°C, there was no expression of MurE protein (54,2 kDa), confirmed with 
SDS-page and as well with Western blot analysis. 
Figure 23: SDS-page and Western blot analysis of MurE protein expression  
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Figure 23.A - SDS-page analysis of 
MurE protein expression at 20°C and 37°C. Figure 23.B - Western blot analysis of MurE protein 
expression at 20°C and 37°C.  
Slika 23: SDS-page in Western blot analiza ekspresije proteina MurE  
Linija je marker, Precision Plus Protein™ Dual Color Standard. Slika 23.A - SDS-page analiza ekspresije 
proteina MurE na 20 °C in 37 °C. Slika 23.B - Western blot analiza ekpresije proteina MurE  
 
Figure 22: SDS-page and Western blot analysis of MurC and MurD protein expression at 37°C 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. 
Figure 22.A - SDS-page analysis of MurC protein expression and MurD expression as positive control.  
Figure 22.B - Western blot analysis of MurC protein expression and MurD expression as positive control. 
Slika 22: SDS-page in Western blot analiza ekspresije proteina MurC in MurD pri 37 °C 
Linija je marker, Precision Plus Protein™ Dual Color Standard. Slika 22.A - SDS-page analiza ekspresije 
proteina MurC in pozitivne kontrole MurD. Slika 22.B - Western blot analiza ekpresije proteina MurC in 
pozitivne kontrole MurD 
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4.1.2 Expression system: insect cells 
 
4.1.2.1 PCR with 8 different strains of C. difficile 
 
Eight different strains of C. difficile (listed in Section 3.1.1) were used to amplify genes of 
interest, murC and murE. Figure 24 shows results of PCR reaction. Both genes were 
successfully amplified from all strains, except from CCOS-940 strain (Figure 24, line 6 for 
both genes). 
 
Figure 24: PCR amplification of murC and murE from different strains of C. difficile 
Lane M is the marker, 1 kb molecular weight standard. Line 1: CCOS-871; Line 2: CCOS-877; Line 3: 
CCOS-937, Line 4: CCOS-938, Line 5: CCOS-940; Line 6: CCOS-941; Line 7: CCOS-957; Line 8: 
CCOS-958. 
Slika 24: PCR amplifikacija murC in murE genov iz različnih sevov C. difficile 
Linija M je marker, 1 kb molekulski standard. Linija 1: CCOS-871; Linija 2: CCOS-877; Linija 3: CCOS-937, 
Linija 4: CCOS-938, Linija 5: CCOS-940; Linija 6: CCOS-941; Linija 7: CCOS-957; Linija 8: CCOS-958. 
 
All PCR products were extracted with NucleoSpin® Gel and PCR Clean-up kit. Further, 
their concentrations were measured with NanoDrop™ and 20 μl of each sample were sent 
for sequencing. 
 
For the further work strains CCOS-871 and CCOS-938 were used. 
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4.1.2.2 Restriction digestion 
 
Genes of interest murC and murE and vector pSIL were prepared for cloning with restriction 
digestion. Figure 25 shows the results of restriction. Both inserts from both strains CCOS-
871 and CCOS-938 were successful digested by restriction enzymes BamHI and HindIII. 
For the further investigation, strain CCOS-871 was used for murC and both CCOS-871 and 
CCOS-938 strains for murE. Digestion mixtures were set up for inserts and plasmid pSIl. 
All fragments were cleaned from the gel using a PCR clean-up kit and ligated as described 
in Section 3.8.2. 
 
4.1.2.3 Plasmid digestion after transformation to 10-beta E. coli competent cells 
 
After ligation, constructs pSIL_RFP::murC and pSIL_RFP::murE were transformed into 10-
beta E. coli competent cells. Single colonies grew on LB+Amp agar. Colonies were used for 
inoculation of liquid LB+Amp for overnight growth. 
Figure 25: Gel electrophoresis after restriction digest of murC and murE 
Line M is the marker, 1 kb molecular weight standard. Line 1 is murC amplified from strain CCOS-
871. Line 2 is murC amplified from strain CCOS-938. Line 3 is murE amplified from strain CCOS-871. 
Line 4 is murE amplified from strain CCOS-938. Genes in all lines were restricted by BamHI, HindIII 
enzymes.  
Slika 25: Gelska elektroforeza po restrikciji murC in murE 
Linija M je marker, 1 kb molekulski standard. Linija 1 je murC amplificiran iz seva CCOS-871. Linija 2 je 
murC amplificiran iz seva CCOS-938. Linija 3 je murE amplificiran iz seva CCOS-871. Linija 4 je murE 
amplificiran iz seva CCOS-938. Geni v vseh linijah so bili rezani z encimoma BamHI in HindIII. 
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After overnight incubation of the culture, plasmid-clean up with NucleoSpin® Plasmid kit 
and plasmid digestion were performed. Plasmid digestion was used for confirmation of 
correct size of insert in clones. Lines 1,6,7,8 in Figure 26 show murC inserts in range of 
correct the size. Correct insert murE is present in lines 9, 15 (strain CCOS-871) and line 21 
(strain CCOS-938). All chosen probes (marked with red in Figure 26) were sent for 
sequencing confirmation.  
Figure 26: Confirmation of successful transformation of constructs into Top10 competent cells  
Lane M is a marker, 1 kb molecular weight standard. Lines 1-8: probes with construct pSIL::murC. 
Lines 9-16: probes with construct pSIL::murE (strain CCOS-871). Lines 17-24: probes with construct 
pSIL::murE (strain CCOS-938). 
Slika 26: Potrditev uspešne transformacije konstruktov v Top10 kompetentne celice  
Linija M je marker, 1 kb molekulski standard. Linije 1-8: vzorci s konstruktom pSIL::murC. Linije 9-16: 
vzorci s konstruktom pSIL::murE (sev CCOS-871). Linije 17-24: vzorci s konstruktom pSIL::murE (sev 
CCOS-938). 
 
4.1.2.4 Isolation of recombinant bacmid DNA 
 
Constructs pSIL_RFP::murC and pSIL_RFP::murE which were positively confirmed by 
sequencing, were transformed to DH10Bac™ Competent Cells. DH10Bac™ host strain 
contains a baculoviral (bacmid) vector that can combine with a donor plasmid to create an 
expression bacmid with a cloned gene of interest. The strain provides a blue-white colony 
screening on plates. White single colonies were used for inoculation of 10 ml liquid media 
LB+kan+tet+gent. After the transformation, bacmid DNA isolation was performed as 
described in Section 3.2.12.  
 
PCR analysis of recombinant bacmid DNA was performed, followed by agarose gel 
electrophoresis to verify the successful transposition to the bacmid. 
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Figure 27 confirms that transposition was successful for both murC and murE.  
 
After the isolation, bacmid DNA concentrations were measured with NanoDrop™. 
 
Table 14: Bacmid DNA concentrations after the isolation 
Preglednica 14: Koncentracije bakmidne DNA po izolaciji 
Mur conc (ng/ul) 
C1 274,9 
C2 329,2 
C3 99,6 
C4 312,1 
E1 196 
E2 115,3 
E3 113,4 
E4 235,8 
 
 
 
4.1.2.5 Fluorescent microscopy results after the transfection of insect cells 
 
Red flourescence protein (RFP) gene was subcloned into plasmid pSIL. RFP was used for 
the detection of the expression of proteins of interest (Roest et al., 2016). 
 
For the evaluation of the outcome of the transfection, marker protein expressed in insect 
cells was observed under flourescent microscope. 
 
 
Figure 27: PCR amplification of isolated bacmid DNA 
Line M: marker, 1 kb molecular weight standard. Lines 1-4: murC. Lines 5-8: murE  
Slika 27: PCR amplifikacija izolirane bakmidne DNK 
Linija M: marker - 1kb molekulski standard. Linija 1-4: murC. Linije 5-8: murE 
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Figure 28: Microscopical observation of insect cells 4 days after the transfection 
Sf9 cells were infected with recombinant bacmid DNA containing red fluorescent marker  
Fig. 28.A - insect cells transfected with murC bacmid DNA. Fig. 28.B - insect cells transfected with 
murE bacmid DNA. Fig. 28.C - insect cells transfected with murD bacmid DNA 
Slika 28: Mikroskopski prikaz žuželčjih celic 4 dni po transfekciji 
Sf9 celice so bile infecirane z rekombinantno bakmidno DNA, ki vsebuje rdeč flourescentni marker 
Slika 28.A - žuželčje celice transfecirane z murC bakmidno DNA. Slika 28.B - žuželčje celice transfecirane 
z murE bakmidno DNA. Slika 28.C - žuželčje celice transfecirane z murD bakmidno DNA 
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Figure 28 shows that transfection was successful for all three proteins observed, MurC, 
MurE and MurD. 
 
Small difference in number of cells suggests that efficient infection could lead to rapid cell 
lysis (Roest et al., 2016).  
 
4.1.2.6 SDS-page and Western blot analysis 
 
After 5 days, cells were harvested and lysed. SDS-page and Western blot analysis followed. 
Results for the expression of both proteins were negative, judged by both analyses. This 
outcome was unexpected based on positive confirmation of expression seen under 
fluorescent microscope (Figure 28).  
 
However, Figures 29 and 30 prove that expressions of MurC and MurE in insect cells were 
not successful.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29: SDS-page and Western blot analysis of MurC expression in insect cells 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Figure 29.A: SDS-page 
analysis of MurC expression. Figure 29.B: Western blot analysis of MurC. Line 1 and 2 in both 
pictures are samples with MurC protein from native DNA  
Slika 29: SDS-page in Western blot analiza ekpresije MurC v žuželčjih celicah 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Slika 29.A: SDS-page analiza ekspresije 
MurC. Slika 29.B: Western blot analiza ekspresije MurC. Liniji 1 in 2 sta vzorca MurC iz nativne DNA. 
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Figure 30: SDS-page and Western blot analysis of MurE expression in insect cells 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Figure 30.A: SDS-page analysis 
of MurE (54,0 kDa) expression. Figure 29.B: Western blot analysis of MurE (54,0 kDa) expression. 
Line 1 and 2 in both pictures are samples with MurE protein from native DNA  
Slika 30: SDS-page in Western blot analiza ekpresije MurE v žuželčjih celicah 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Slika 31.A: SDS-page analiza ekspresije 
MurE (54,0 kDa). Slika 30.B: Western blot analiza ekspresije MurE (54,0 kDa). Liniji 1 in 2 sta vzorca MurE 
iz nativne DNA. 
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4.2 SYNTHETIC DNA OF C. difficile 
 
Synthetic DNA (murE, murF and murG genes) of C. difficile was obtained from Thermo 
Fisher Scientific. Each gene was assembled from synthetic oligonucleotides and/or PCR 
products. The inserts were cloned into vector pFastBac1. The DNA was optimized for the 
expression in E. coli and insect cells. 
 
4.2.1 Expression system: E. coli 
 
4.2.1.1 PCR check for inserts 
 
First, PCR amplification of genes of interest was performed to check for the presence of 
correct inserts in provided vector pFastBac1. Primers used for the reaction are listed in 
Section 3.2.1.4, Table 13. PCR results confirmed correct size and positive presence of all 
targeted genes, murE (Fig. 31, Lines 1 and 2), murF (Fig. 31, Lines 3 and 4) and murG (Fig. 
31 Lines 5 and 6). 
 
 
 
 
 
 
 
 
Figure 31: Confirmation of correct inserts presence in pFastBac1 with PCR amplification of the genes 
Line M: the marker, 1 kb molecular weight standard. Lines 1,2: murE. Lines 3,4: murF. Lines 5.6: murG. 
Slika 31: Potrditev prisotnosti pravilnih insertov v pFastBac1 s PCR amplifikacijo genov  
Linija M: marker, 1 kb molekulski standard. Liniji 1 in 2: murE. Liniji 3 in 4: murF. Liniji 5 in 6: murG. 
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4.2.1.2 Restriction digest 
 
Synthetic genes were provided in pFastBac1 vector. For the expression in E. coli, genes 
needed to be cloned into pET28a expression vector. For this reason, restriction digest was 
performed first to digest genes of interest. Restriction enzymes BamHI and HindIII 
successfully cut inserts (Figure 32). All three genes of interest, murE, F and G were of a 
correct size. As well, plasmid vector pET28a was digested with BamHI and HindIII allowing 
successful ligation of both DNA fragments. Restriction products were cut of the gel and 
extracted with NucleoSpin® Gel and PCR Clean-up kit.  
 
 
Purified insert and vector DNA were ligated following the protocol in Section 3.2.8. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Restriction digest of constructs murE::pFastBac1, murF::pFastBac1 and murG::pFastBac1 
Line M: the marker; 1 kb molecular weight standard. Line 1: murE and pFastBac1 after restriction. 
Line 2: murF and pFastBac1 after restriction. Line 3: murG and pFastBac1 after restriction. Line 4,5: 
Restricted pET28a expression vector 
Slika 32: Restrikcija konstruktov murE::pFastBac1, murF::pFastBac1 in murG::pFastBac1 
Linija M: marker, 1 kb molekulski standard. Linija 1: murE in pFastBac1 po restrikciji. Linija 2: murF in 
pFastBac po restrikciji. Linija 4: murG in pFastBac po restrikciji. Liniji 4 in 5: vector pET28a po restrikciji 
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4.2.1.3 Plasmid digestion after transformation to Top10 E. coli competent cells 
 
Plasmid pET28a and insert were ligated and transformed to Top10 E. coli competent cells. 
Therefore, plasmid digestion was performed as confirmation of successful cloning of murE-
murG genes into pET28a. Figure 33 shows positive results for all constructs: pET28a::murE, 
pET28a::murF and pET28a::murG. 
 
4.2.1.4 Plasmid digestion after transformation to BL21 competent cells 
 
In the next step, constructs pPET28a::murE, pPET28a::murF and pPET28a::murG were 
transformed into BL21 E. coli strain, which was used as host for overproduction of Mur 
ligases. Successful transformation was confirmed by plasmid digestion. Digestion was 
performed with the same restriction enzymes as restriction digestion at the beginning of 
cloning, BamHI and HindIII. In lines 1-4 presence of murE (Fig. 34) was confirmed with 
correct size of 1467 bp, in lines 5-8 murF (1386 bp) was confirmed and murG (1239 bp) as 
well in lines 9-12.  
 
 
 
Figure 33: Confirmation of the presence of correct clones in Top10 E. coli competent cells 
performed with plasmid digestion  
Line M: the marker, 1 kb molecular weight standard. Lines 1-6: correct size of insert murE and 
vector pET28a. Lines 7-12: correct size of insert murF and vector pET28a. Lines 13-18: correct size 
of insert murG and vector pET28a 
Slika 33: Potrditev prisotnosti pravilnih klonov v Top10 E. coli kompetentnih celicah s plazmidno 
restrikcijo 
Linija M: marker, 1 kb molekulski standard. Linije 1-6: pravilna velikost inserta murE in pET28a. Linije 
7-12: pravilna velikost inserta murF in vektorja pET28a. Linije 13-18: pravilna velikost inserta murG in 
vektorja pPET28a.   
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For protein expression, probe 1 for murE, probe 4 for murF and probe 1 for murG were 
chosen. 
 
4.2.1.5 SDS-page and Western blot analysis of MurE, F, G and MurD after protein 
expression 
 
After the transformation of constructs pPET28a::murE, pPET28a::murF, pPET28a::murG 
and pPET28a::murD, to BL21 E. coli host strain, the protein expression was performed. For 
the prevention of cell lysis and formation of inclusion bodies, temperature of 20°C was used 
for the expression. 
 
Overnight precultures were used for inoculation of 100 ml of LB supplemented with 
kanamycin. When optical density at 600 nm reached around 0.6, expression was induced 
with 1 ml of IPTG. 
 
During each protein expression process, samples were taken each hour for three hours after 
the induction with IPTG and the last one was taken after overnight incubation. Growth rates 
were measured with spectrophotometer at OD600. Figure 35 shows how cell concentration 
increased with the time during the protein expression. Growth rates of E. coli were satisfying 
in all the points observed (0 h, 1 h, 2 h, 3 h and 18 h). Overnight growth measurement was 
high and that indicates no cell lysis or toxicity was presented.  
Figure 34: Confirmation of presence of correct inserts after transformation in BL21 E. coli strain 
performed with plasmid digestion 
Line M: the marker, 1 kb molecular weight standard 
Line 1-4: probes with murE as insert. Lines 5-8: probes with murF as insert. Lines 9-12: probes with 
murG as insert 
Slika 34: Potrditev prisotnosti pravilnih insertov po transformaciji v BL21 E. coli sev z plazmidno restrikcijo 
Linija M: marker, 1 kb molekulski standard. Linija 1-4: vzorci z insertom murE. Linije 5-8: vzorci z insertom 
murF. Linije 9-12: vzorci z insertom murG. 
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SDS-page and Western blot analyses showed positive protein expression of MurE (Figure 
36), MurF (Figure 37), MurG (Figure 38) and MurD (Figure 39) as positive control. 
 
 
Figure 36: SDS-page and Western blot analysis of MurE expression 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Figure 36.A: SDS-page analysis 
of MurE expression. Figure 36.B: Western blot analysis of MurE expression. 
Slika 36: SDS-page in Western blot analiza ekpresije MurE 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Slika 36.A: SDS-page analiza ekspresije 
MurE. Slika 36.B: Western blot analiza ekspresije MurE 
 
 
 
Figure 35: Growth rate of BL21 E. coli expression host strain 
Slika 35: Vrednosti rasti ekspresijskega gostiteljskega seva BL21 E. coli 
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Figure 37: SDS-page and Western blot analysis of MurF expression 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Figure 37.A: SDS-page analysis of 
MurF expression. Figure 37.B: Western blot analysis of MurF expression. 
Slika 37: SDS-page in Western blot analiza ekpresije MurF 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Slika 37.A: SDS-page analiza ekspresije 
MurF. Slika 37.B: Western blot analiza ekspresije MurG. 
 
Figure 38: SDS-page and Western blot analysis of MurG expression 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Figure 38.A: SDS-page 
analysis of MurG expression. Figure 38.B: Western blot analysis of MurG expression. 
Slika 38: SDS-page in Western blot analiza ekpresije MurG 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Slika 38.A: SDS-page analiza 
ekspresije MurG. Slika 38.B: Western blot analiza ekspresije MurG 
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4.2.1.6 SDS-page and Western blot analysis of MurE and MurD after protein purification 
 
MurE 
For the recombinant protein purification MurE was chosen. As positive control of the 
experiment, MurD was analysed.  
 
Protein purification was performed with the supernatant fraction of the protein production. 
Fractions in the volume of 1 ml were collected based on the chromatogram (Figure 40).  
Figure 39: SDS-page and Western blot analysis of MurD expression 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Figure 39.A: SDS-page analysis 
of MurD expression. Figure 39.B: Western blot analysis of MurD expression 
Slika 39: SDS-page in Western blot analiza ekpresije MurD 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Slika 39.A: SDS-page analiza ekspresije 
MurD. Slika 39.B: Western blot analiza ekspresije MurD 
 
 
Figure 40: Chromatogram of MurE protein purification process 
Slika 40: Kromatogram čiščenja MurE proteina 
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SDS-page and Western blot analyses of the fractions, pelet, supernatant and flow-through 
were performed. The SDS-page analysis showed high amount of protein in fractions 11, 12 
and 13, and a little lower amount in fractions 8, 9, 10, 14 and 15 in a size around 55 kDa. 
Protein size of MurE is 54,0 kDa, which positively correlate to the protein detected with 
SDS-page. Presence of MurE was confirmed with immunodetection in all elution fractions. 
 
However, the SDS-page showed the presence of other proteins too. Therefore, further 
cleaning step with size exlusion chromatography was needed to be performed.   
 
MurD 
The same analysis was performed for positive control, MurD. Fractions used for the analysis 
were selected based on the chromatogram after IMAC (Figure 42).  
Figure 41: SDS-page and Western blot analysis of MurD after size immobilized metal-affinity chromatography 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Lanes: pel - pellet obtained from the 
production culture, sn - supernatant, ft - flow-through, 4-15 - elution purification fractions 
Slika 41: SDS-page in Western blot analiza MurD po imobilizirani kovinski afinitetni kromatografiji 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Linije: pel-pelet, sn-supernatant, ft-flow-through, 4-
15 frakcije čiščenja 
 
Figure 42: Chromatogram of MurD protein purification process 
Slika 42: Kromatogram čiščenja proteina MurD 
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4.2.1.7 SDS-page and Western blot analysis after size exclusion chromatography 
 
The SDS-page analysis showed high amount of protein in fractions 3, 4, 5, 6, 7, 8 and lower 
amount in fractions 9, 10 in size of 50 kDa, which positively correlate to the size of MurD. 
Presence of MurD was confirmed with immunodetection. The same as with MurE, the SDS-
page analysis of MurD fractions showed that further cleaning was needed to be performed.  
 
After protein purification with IMAC, further cleaning of the proteins was performed with 
size exclusion chromatography (also known as gel filtration), which separares molecules by 
differences in size. Based on chromatogram in Figure 44, fractions were selected and used 
for SDS-page and Western blot analyses of MurE.  
Figure 44: Chromatogram of MurE size exclusion chromatography 
Slika 44: Kromatogram MurE po velikostni izključitveni kromatografiji 
Figure 43: SDS-page and Western blot analysis of MurD after size immobilized metal-affinity 
chromatography  
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Lanes: pel - pellet obtained 
from the production culture, sn - supernatant, ft - flow-through, 3-10 - elution purification 
fractions 
Slika 43: SDS-page in Western blot analiza MurD po imobilizirani kovinski afinitetni kromatografiji 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Linije: pel-pelet, sn-supernatant, ft-
flow-through, 3-10 frakcije čiščenja 
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Figure 45 shows that the gel filtration was successful and MurE protein was much cleaner 
than before this polishing step. However, Figure 45.A represents the result of SDS-page 
analysis and still, there was still presence of some other proteins in fractions. However, MurE 
was more pure that before gel filtration experiment. Western blot analysis was performed to 
positively confirm the results of SDS-page with immunodetection (Fig, 45.B).  
Based on chromatogram in Figure 46 fractions from gel filtration of MurD were selected for 
further analysis. 
 
Figure 46: Chromatogram from MurD size exclusion chromatography 
Slika 46: Kromatogram velikostne izločevalne kromatografije MurD 
Figure 45: SDS-page and Western blot analysis of MurE after size exclusion chromatography 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Lines: pel - pellet obtained from the 
production culture, sn - supernatant, ft - flow-through, 8-15; 21-24 - elution purification fractions 
Slika 45: SDS-page and Western blot analiza of MurE po imobilizirani kovinski afinitetni kromatografiji 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Linije: pel-pelet, sn-supernatant, ft-flow-through, 8-
15; 21-24 frakcije čiščenja 
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Figure 47 shows positive results for MurD. Bands in size around 50 kDa are presented in 
SDS-page analysis, which positively correlates with MurD size of 49,49 kDa. The results 
were confirmed with immunodetection after Western blotting (Figure 47.B). 
 
4.2.1.8 SDS-page and Western blot analysis after Amicon® centrifugation 
 
Fractions were collected and centrifuged in Amicon® centrifugal filter units, to be more 
concentrated. Concentrations of proteins were measured with NanoDrop™. 
 
Table 15: Protein concentrations after the size exclusion chromatography and concentration with filters  
Preglednica 15: Koncentracije proteinov po velikostni izločevalni kromatografiji in koncentriranju proteina s 
filtri 
Protein Concentration (mg/ml) 
MurE 1,86 
MurD 1,96 
 
Recovery and the confirmation of presence of MurE and MurD after the centrifugation were 
performed with SDS-page and Western blot analyses. Figure 48 shows positive results for 
both proteins on the SDS page - MurE in size 54,0 kDa and MurD 49,5 kDa.  
                   
 
 
 
 
Figure 47:  SDS-page and Western blot analysis of MurD after size exclusion chromatography  
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Lines: pel - pellet obtained from the 
production culture, sn - supernatant, ft - flow-through, 8-15; 21 - elution purification fractions 
Slika 47: SDS-page in Western blot analiza MurD po velikostni izločevalni kromatografiji 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Linije: pel - pellet, sn - supernatant, ft - flow-
through, 8-15; 21 - frakcije 
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4.2.1.9 Inhibitory assay 
 
Purified and concentrated MurE protein was used for inhibitory assay. Assay was performed 
with several inhibitors listed in Section 3.1.12. Potential inhibitory effect was tested with 
different extracts from different Streptomyces species. Most of them are still quite 
unexplored. For some of them the active ingredient was identified, thus not for all. Detailed 
information known about all the extracts used in the work is listed in Section 3.1.12.  
 
Inhibitory assay was performed with ProFoldin MurE Assay Kit Plus. Reaction is based on 
measurement of the inorganic phosphate generated from the reaction. Phosphate was 
detected by light absorbance at 650 nm.  
 
First, the inhibitory assay was performed with MurE enzyme from E. coli provided by kit. 
In positive control (PK_E.coli) was confirmed that enzyme and its substrate positively 
perform reaction. Figure 49 shows that there is no inhibitory activity for any of tested 
potential inhibitors.  
 
 
Figure 48: SDS-page and Western blot analysis of concentrated MurE and MurD  
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Line E - MurE, Line D - 
MurD. Figure 48.A - SDS-page analysis of MurE and MurD after concentration. Figure 48.B - 
Western blot analysis of MurE and MurD after concentration 
Slika 48: SDS-page in Western blot analiza koncentriranih MurE in MurD 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Linija E - MurE, Linija D - MurD. 
Slika 48.A - SDS-page analiza MurE in MurD po koncentraciji. Slika 48. B - Western blot analiza MurD 
in MurE po koncentraciji. 
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Figure 49: Inhibitory assay performed with MurE from E. coli provided by ProFoldin Kit 
Slika 49: Test inhibicije MurE encima iz E. coli, ki je del ProFoldin kita 
 
Figure 50 presents the assessment of inhibition of MurE protein from C. difficile. Amount 
of released inorganic phosphate was measured at 650 nm, as well as with the enzyme from 
kit.  
 
Results are the same as with MurE enzyme from the kit. All potential inhibitors (A52, B11, 
C10, Wurm499, A6, fosfomycin) showed no inhibition. D-cycloserin was tested, as it was 
positively confirmed as MurE inhibitor by Eniyan et al. (2016) in their study on Mur ligases 
from Mycobacterium tuberculosis. However, D-cycloserin did not show inhibitory activity 
on MurE from C. difficile.  
 
 
Figure 50: Inhibitory assay performed with recombinant C. difficile MurE 
Slika 50: Test inhibicije rekombinantnega MurE encima iz C. difficile  
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4.2.2 Expression system: insect cells 
 
4.2.2.1 PCR check for inserts in vector pFastBac™ 
 
Synthetic genes murE, murF and murG were provided by Thermo Fisher Scientific. The 
genes were cloned into vector pFastBac1. PCR amplification of genes of interest was 
performed with primers outlined in Section 3.2.1.4, Table 13. PCR analysis was carried out 
to confirm presence of correct size of insert in provided vectors.  
 
Figure 51 shows that all three inserts were present and of a correct size. Size of murE (Fig. 
51, Lines 1 and 2) was 1467 bp, murF (Fig. 51, Lines 3 and 4) 1386 bp and of murG 1239 
bp (Fig. 51, Lines 5,6).  
 
4.2.2.2 Bacmid DNA isolation  
 
Provided constructs pFastBac1::murE, pFastBac1::murF and pFastBac1::murG were 
transformed into DH10 Bac™ competent cells. After transformation, bacmid DNA was 
isolated according to the protocol in Section 3.2.16.  
 
After the isolation, bacmid DNA concentrations were measured with NanoDrop™. 
 
  
Figure 51: Confirmation of murE, murF and murG presence in pFastBac1 vector 
Line M: the marker, 1 kb molecular weight standard. Lines 1,2: murE. Lines 3,4: murF. Lines 
5,6: murG. 
Slika 51: Potrditev prisotnosti murE, murF in murG v pFastBac vektorju 
Linija M: marker, 1 kb molekulski standard. Linija 1,2: murE. Linija 3,4: murF. Linija 5,6: murG. 
   
Pušić M. Detection of potential actinobacterial inhibitors of bacterium Clostridium difficile Mur ligases. 84 
   M.Sc. Thesis (Du2). Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Microbiology, 2019 
  
Table 16: Bacmid DNA concentrations after isolation 
Preglednica 16: Koncentracije bakmidne DNA po izolaciji 
Bacmid DNA of 
murX 
Probe 1  
[ng/μl] 
Probe 2 
[ng/μl] 
Probe 3 
[ng/μl] 
Probe 4 
[ng/μl] 
murE 1021,7 775,1 813,9 735,4 
murF 765,9 1025,7 870,7 427,2 
murG 541,6 893,4 803,4 833,6 
 
4.2.2.3 SDS-page and Western blot analysis of harvested samples from insect cell based 
protein expression 
 
Bacmid DNA was used for the transfection of insect cells. For the transfection two probes 
of each mur gene were used. Probes were selected based on concetration. The goal was that 
all probes have concentration in the same range. Probes used are underlayed in Table 18. 
Successful transfection and the start of viral production was investigated under the 
microscope. Cells became bigger, more granular, they stopped to divide and they detached 
from the surface of a six well plate. In comparion to insect cell based protein expression with 
native DNA, here the flourescent marker was not provided. Therefore, the check up with 
flourescent microscope was not possible. 
 
After the cells were harvested, SDS-page and Western blot analyses was performed. Both 
analyses proved successful virus production of target proteins MurE (Figure 52, Lines: 1,2), 
MurF (Figure 52, Lines: 3,4) and MurG (Figure 52, Lines: 5,6).  
 
As positive control of the expression MurD was used. MurD was successfully expressed. In 
negative control no DNA was used, therefore no expression was aknowledged, as expected. 
Due to the time course, further analysis was not performed. 
Figure 52: SDS-page and Western blot analysis of MurE, MurF and MurG protein expression in 
insect cells 
Lane M is the marker, Precision Plus Protein™ Dual Color Standard. Lanes 1,2: MurE. Lines 3,4: 
MurF. Lines 5,6: MurG. Line 7: positive control. Line 8: negative control 
Slika 52: SDS-page in Western blot analiza ekspresije proteinov MurE, MurF in MurG v žuželčjih celicah 
Linija M je marker, Precision Plus Protein™ Dual Color Standard. Linije 1,2: MurE. Linije 3,4: MurF. 
Linije 5,6: MurG. Linija 7: pozitivna kontrola. Linija 8: negativna kontrola. 
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5 DISCUSSION 
 
Antibiotic resistance is a huge public health problem nowadays. Therefore, it is necessary to 
find new potential targets for new antibiotics. The first phase of peptidoglycan biosynthesis, 
which is catalysed by Mur enzyme family, showed great potential for being a source of new 
targets. In this reason, this study is focused on Mur ligases from bacterium C. difficile. C. 
difficile infections became a growing problem for public health as virulent strains result in 
higher morbidity and mortality (Peng et al., 2017). One of the goals of C. difficile researches 
is to find new antibiotic targets as new antibiotic resistances are evolving and to develop 
antibiotics with narrow anti-C. difficile spectrum (Spigaglia, 2016).  
 
The goal of this master thesis was to detect different potential inhibitors of Mur ligases from 
C. difficile. Mur ligases had shown great potential in being a target for new potential 
antibiotics as they are crucial for cell integrity. They catalyse assembly of peptidoglycan. 
Biosynthetic machinery for synthesis of peptidoglycan so far represents an excellent target 
for antimicrobials. However, most antimicrobials target later stages of biosynthesis. Mur 
ligase family catalyses the first stage of peptidoglycan assembly, towards which not many 
inhibitors have been found yet. As well, Mur ligases are not present in eukaryotes. All 
mentioned so far, make Mur enzymes excellent potential drug targets (Eniyan et al., 2016). 
 
Before final inhibitory assay with different potential inhibitors isolated from Actinobacteria 
was carried out, this work had three parts: molecular cloning of mur genes, expression, and 
purification of recombinant Mur proteins. Whole work was performed with native, wild-type 
DNA and synthetic DNA of C. difficile. 
 
Molecular cloning 
Molecular cloning of Mur ligases genes into an appropriate vector was performed as 
preparation for the expression of the protein of interest in the eukaryotic and prokaryotic 
system. Vector was chosen based on the expression system. For both types of DNA, native 
and synthetic, a vector for the expression in E. coli was pET28a. For the expression in insect 
cells pSIL (native DNA) and pFastBac1 (synthetic DNA) vectors were used. Native DNA 
was beforehand isolated and provided by CCOS, Culture Collection of Switzerland. 
Synthetic DNA was produced and provided by Thermo Fisher. Therefore, no DNA isolation 
was needed before the cloning procedure.  
 
PCR was performed for both types of DNA. Primers listed in Table 11 were used and gave 
rise to DNA fragments of expected size for all genes of interest. C. difficile is generally 
known as genetically hard to modify (Bouillaut et al., 2011). Cloning with native DNA was 
therefore hard to perform due to many restriction sites presented in the insert. This is quite 
unusual since mur genes are small fragments in size around 1000-1500 bp. Even though 
sequences were checked before, most common restriction enzymes would still cut the insert 
during the restriction reaction. murC had even more complexity as restriction enzyme XhoI 
sometimes did not cleave completely (Figure 16). This problem was due to DNA 
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methyltransferases. These enzymes catalyse the transfer of the methyl group on specific sites 
on the DNA sequence (Bheemanaik, 2006). These sites can overlap with restriction sites of 
restriction enzymes. In the case of murC, Cpg methylase’s sequence is located inside the 
recognition site of XhoI and that can result in impaired cleavage (ThermoFisher, 2019a). 
 
To find best working strain, eight different strains of C. difficile were used for gene 
amplification, sequencing, and identification of restriction sites presented in a given 
sequence. The results showed the best strains were CCOS-871 (used for MurC) and CCOS-
938 (used for MurE). The work successfully proceeded with these two strains.  
 
In comparison to challenging cloning with native DNA, synthetic DNA had already been 
optimized for expression in insect cells and E. coli, therefore no problems with cloning 
occurred. Molecular cloning with synthetic DNA was performed only for preparing the 
constructs for expression in E. coli. Synthetic genes were provided in pFastBac1 and 
transferred to E. coli pET28a vector expression vector. As predicted, restriction enzymes 
BamHI and HindIII successfully cut the insert out and ligation was carried out without 
problems.  
 
To conclude this part, if we compare both DNA origins used in this work, it was expected 
and confirmed that molecular cloning of synthetic DNA is a way easier and accompanied 
with fewer difficulties that molecular cloning of native DNA. However, cloning was 
performed successfully and ready for protein expression. 
 
Protein expression in E. coli and insect cells  
Mur proteins were expressed in two different expression systems, prokaryotic and 
eukaryotic.  
 
Prokaryotic expression was performed in E. coli. Special expression E. coli host strain BL21 
was used. As expected from cloning experience, the expression of proteins from constructs 
from native DNA of C. difficile was harder to perform. First attempt to express MurC and 
MurE was rather unsuccessful. When wild-type genes are transformed to heterologous host 
for the expression, the outcome is usually a low expression of recombinant proteins. The 
native DNA genes are not evolved for optimum expression in the host (Chung and Lee, 
2016). Therefore, the results of SDS-page and Western blot analysis, which were negative 
for both proteins studied, were not surprising. However, the solutions how to at least improve 
or resolve the problem of expression were investigated and analysed. Nouri et al. state in 
their article that codon bias highly affects the expression of proteins in E. coli. In this reason, 
host strain was changed. Constructs pET28a::murC/murE were transformed into BL21-
Codon Plus E. coli strain. BL21-Codon Plus cells are modified cells and contain additional 
copies of E. coli’s rarely used codons for amino acids (Kleber-Janke and Becker, 2000). This 
strain allows better, high level protein expression and solves the problem of codon bias. 
Furthermore, the influence of temperature on the level of protein expression was studied. 
Two different temperatures of E. coli culture’s incubation (20°C and 37°C) were analysed. 
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Literature shows that some proteins are expressed in higher concentration at a lower 
temperature in comparison to the usual 37°C. As well, lower temperature of expression can 
resolve the problem of inclusion bodies (Patin et al., 2018). Figure 17 shows that decreased 
temperature down to 20°C positively influenced E. coli growth. E. coli growth during the 
expression of MurC was much higher at 20°C than 37°C. On the other hand, MurE showed 
the opposite. The results are pointing out that each protein expressed performed differently 
and that ideal expression parameters should be found independently for each protein. 
Gräslund et al. presumed that a lower temperature of the expression can help to fold protein 
properly and therefore leading to higher protein yield at the end of production. We assumed 
that the higher growth rate of E. coli would positively correlate to higher expression of 
recombinant proteins. However, that was not confirmed with native, wild-type DNA. Judged 
by SDS-page and Western blot analysis there was no protein expression for both proteins at 
both temperatures studied. In parallel, positive control MurD, performed positively and was 
overexpressed at both temperatures. Patin et al. (2010) in research on Mur ligases from S. 
aureus showed high IPTG concentration can lead to lysis effect and reducing the 
concentration down to 100 μM can avoid the toxicity effect. As well proteins mostly remain 
in soluble fraction then. IPTG concentration gradient was not tested in this work due to the 
time course. There can be spotted a decrease in E. coli growth and this can confirm the 
potential toxic effect of our proteins on the cells. It is possible the product of the expression 
can be lethal for host strain. Therefore, due to proteins toxicity on E. coli cells, 
overproduction could be not achieved (Dumon-Seignovert et al., 2004). 
 
From all mentioned, we can conclude that expression conditions are specific to each protein 
independently, even though our proteins studied were from the same enzyme family. The 
most probable reason why expression was not successful is that MurC and MurE proteins 
were toxic for E. coli strain as there can be clearly spotted decrease in E. coli growth after 
overnight incubation. Decreased temperature improved the situation; however, this also did 
not bring a positive result. To successfully perform the expression of recombinant proteins 
constructed from from wild-type C. difficile more research on ideal conditions must be 
carried out.  
 
Synthetic DNA of C. difficile Mur ligases showed the different outcome of the expression. 
All three proteins, MurE, F and G, were successfully overexpressed in BL21 E. coli 
expression strain. The result was confirmed with positive control MurD, which was also 
expressed in parallel. Protein expression was positively confirmed for all four proteins with 
SDS-page and Western blot analysis as can be seen in Figures 36, 37 and 38. Synthetic DNA 
was codon optimized for the expression in E. coli, therefore this outcome was expected. One 
of the most important factors of gene expression level is an adaptation of codon usage of the 
gene to the codon usage of the host (Puigbò et al., 2007). Constructed sequences have 
effective mRNA translational efficiency due to individual codon usage (Chung and Lee, 
2012). In this reason, this part of the experiment was a success.  
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Prokaryotic expression was performed in Spodoptera frugiperda Sf9 cells. Genes from 
native DNA were cloned into pSIL vector. pSIL had been modified with a red fluorescent 
protein (RFP). RFP allowed observing the level of protein expression under the fluorescent 
microscope. Cells with induced expression would express RFP and appear red. Figure 25 
one shows that protein expression was successfully induced, and cells started to overexpress 
MurC and MurE. After 5 days cells were harvested. Protein expression was investigated with 
SDS-page and Western blot analysis. Both analyses showed a negative result, which was not 
expected as RFP could be detected under the microscope. Baculoviral DNA was confirmed 
by PCR analysis, therefore, the absence of gene of interest can be also ruled out. No protein 
yield after expression can be due to cell line, which could not be optimal for our proteins. 
More, cell growth condition and medium could also not be optimal for our protein 
expression. As well, too low or too high viral titer could be used (ThermoFisher, 2019b). 
Further investigation was not performed due to the time course.  
 
In synthetic constructs fluorescent marker was not provided. Therefore, cells were observed 
under the microscope for signs of a successful infection. In early phase cells become bigger, 
later they stop growing and start to release the plate. Cells were harvested at an appropriate 
time and afterwards lysed with buffer. At last, samples were analysed with SDS-page and 
Western blot. All three protein studied, MurE, F and G were overexpressed, confirmed by 
both analyses. Due to time course further analysis was not performed with proteins from 
insect cells.  
 
For protein purification and the inhibitory assay was chosen MurE protein obtained in E. 
coli expression system. 
 
Protein purification 
Initial purification step was immobilized metal affinity chromatography (IMAC). Before 
purification, the bacterial lysate was prepared and loaded on the IMAC column. Each protein 
was purified by binding to Ni-NTA residues on the column with His-tag. Based on 
chromatogram fractions, collected during the chromatography, were picked and resolved by 
SDS-page and Western blot analysis. Figure 41 shows a positive presence of purified MurE 
protein. The intensity of the bands is usually proportional to the amount of protein (Gräslund 
et al., 2008). As well it could be confirmed that the purified MurE protein is of the expected 
size. Judged by SDS-page and Western blot analyses of IMAC fractions, a protein was set 
for one more step of purification as additional proteins were present in fractions too. The 
further polishing step was performed with size-exclusion chromatography in order to remove 
contaminants. Gel filtration allowed examination of the stability and quality of the purified 
protein. This step efficiently removed some of the additional proteins. Thus, it was not 
possible to purify the complex to homogeneity as some amount of additional proteins 
remained in protein material. These proteins could be of E. coli origin since the 
copurification of E. coli proteins with the histidine-tagged proteins is very frequent 
(Gräslund et al., 2008). Possibly these additional proteins could have an impact on the 
outcome of the inhibitory assay later.  
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Expression and purification were not successful for any construct from wild-type DNA of 
C. difficile. On the other hand, the expression and purification for all constructs from 
synthetic DNA performed very well in both parts of the experiment mentioned. This is 
expected due to fact that synthetic DNA is codon optimized for the experiment. However, it 
was expected to see some activity also with native DNA. Unfortunately, all results were 
negative. Due to the time course further investigation of possible reasons was not possible. 
 
After the purification, MurE protein was concentrated by using centrifuge-driven filter 
devices and used for the inhibitory assay. 
 
In-vitro inhibitory assay performed with MurE   
Most of the inhibitors of C. difficile known today inhibit enzymes in the later stage of 
peptidoglycan synthesis. Therefore, Mur enzymes are therefore a great potential source of 
new inhibitors, as these initial intracellular steps of the biosynthesis remain mostly 
unresearched (Eniyan et al., 2016). 
 
The aim of this work was to test potential inhibitors of purified protein MurE with in-vitro 
inhibition method. The initial assay involved MurE enzyme provided by kit and purified 
MurE from C. difficile, and its substrates UDP-MurNAc-L-Ala-D-Glu (UDP-MurNAc-
dipeptide, UMAG) and meso-diaminopimelic acid. MurE Assay is based on the 
measurement of the inorganic phosphate produced in the MurE reaction with substrates.  
 
 
 
 
The assay was performed in a 96-well assay plate. Measurement of phosphate production as 
result of reaction between protein of interest MurE from C. difficile and its substrate, 
positively confirms that protein expressed and purified has been active. As well, this is a 
positive control of whole assay. Positive control was also positively performed with Mur 
enzyme from the kit and its substrates. 
 
The inhibitory assay was performed with several potential inhibitors, isolated from 
Actinobacteria as well as with some known inhibitors found in the literature. Two known 
and clinically approved inhibitors were used. First, fosfomycin has proven successful 
targeting MurA, binding to cysteine in the active site of MurA (Falagas et al, 2016). 
Therefore, potential inhibition of purified MurE ligase by fosfomycin was tested. What is 
more, D-cycloserin, as clinically approved drug for tuberculosis, was as well tested for the 
Figure 53: MurE enzymatic reaction (ProFoldin, 2019) 
Slika 53: Encimska reakcija MurE (ProFoldin, 2019) 
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inhibition as it targets D-alanin-D-alanine ligase. On the research on Mycobacterium 
tuberculosis, D-cycloserin was confirmed as inhibitor of Mur pathway (Eniyan et al., 2016). 
D-cycloserin is antibiotic known to be found in selective media for C. difficile growth as 
strains are resistant to that antibiotic. This explains no inhibition activity towards researched 
MurE ligase, probably resistant to D-cycloserin. 
 
In parallel, two inhibitory assays were performed. One with MurE ligase provided by kit and 
other with purified and concentrated MurE from synthetic DNA of C. difficile. The same 
amount of all the inhibitors listed in Section 3.1.12 were used for both assays. Unfortunately, 
Figures 49 and 50 show that results were negative for all the inhibitors tested. One could see 
that with every inhibitor used similar amount of phosphate released could be measured. In 
parallel, the negative control was performed separately. In negative control assay were tested 
methanol and HCl. Methanol was tested for potential inhibition as most of extracts were 
stored it, and HCl was tested because fosfomycin needed to be prepared as working solution 
in 1M HCl. The results show that both, HCl and methanol, have an effect to reaction and 
inhibit phosphate release. This explains the highest absorbance value for extract Wurm499, 
which was the only one not stored in methanol. 
 
Taking into picture all this, we can conclude that there were no potential inhibitions from 
Actinomyces founded. As well, influence of methanol and hydrochloric acid on the 
inhibition level was detected. Therefore, adjustment of extracts storage media should be 
performed first. As well, a preparation of working solution of fosfomycin should be changed 
as substitution for HCl should be found. Due to time course further analysis was not 
performed. 
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6 CONCLUSION 
 
The first aim of this work was to obtain and to analyse the activity of Mur ligases from C. 
difficile. As proposed, it was proved possible to obtain an active recombinant MurE ligase 
from C. difficile. The goal was reached with synthetically provided DNA for MurE ligase. 
The activity was proved in a reaction with MurE substrates, UDP-MurNAc-dipeptide and 
meso-diaminopimelic acid. On the other side, our hypothesis was wrong in case of wild-type 
DNA of Mur ligases, as we could not obtain any Mur ligase from the expression. Therefore, 
further analysis of the activity was not possible.  
 
MurE ligase was successfully obtained and active. Protein was proved by SDS-PAGE and 
immunoblotting and concentrated for the inhibitory assay. However, last step of purification 
showed that protein is not completely homogeneous. Results of inhibitory assay have shown 
that our hypothesis that we will find some potential inhibitors of Mur ligases, is refused. No 
potential inhibitory activity was detected. 
 
This experiment confirmed that setting of the experiment is promising and effective and 
therefore could lead to detection of some new inhibitors from Actinobacteria in the future.  
However, process is highly complex and a lot of adjustments of whole experiment are needed 
to be considered.  
 
This study was limited in terms of time and for more precise evaluation of potential inhibitors 
it is necessary to conduct a deeper analysis of the experiment settings.  
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7 SUMMARY (POVZETEK) 
 
7.1 SUMMARY 
 
Clostridium difficile is Gram positive, toxin-producing bacterium. In human, it is leading 
cause of diarrhoea, which is mediated by two exotoxins. C. difficile infections are most often 
due to exposure to antibiotics which are not active against the bacterium (Ofosu, 2016). What 
is more, CDI is treated with oral antibiotics as metronidazole and vancomycin. In last decade, 
the significant susceptibility to these antibiotics emerged, as many resistant strains evolved. 
CDI infections are only one example of huge health issue of this era, antibiotic resistance 
(Peng et al., 2017). Standard treatment for CDI mentioned above are broad-spectrum 
antibiotics that result in killing C. difficile and as well, in disruption of normal microbiota. 
That increases risk for relapse of infection and decreases ability of defence towards CDI. 
This represents main clinical issue connected to CDI, therefore there are many studies 
focused on finding new potential targets for new more wide-spectrum antimicrobial agents. 
In case of C. difficile, one of the most researched and promising new targets nowadays are 
Mur ligases, enzymes catalysing the peptidoglycan assembly.  
 
Mur ligase family is a group of promising new targets and therefore this thesis is focused on 
Mur ligases from C. difficile. The aim of the work was to obtain active recombinant Mur 
ligases from wild-type C. difficile DNA. This aim was expanded and included also synthetic 
provided C. difficile DNA. We constructed plasmids which contain genes of interest and we 
used them for expression in prokaryotic and eukaryotic system. Wild type DNA of Mur 
ligases did not show positive results of expression. Therefore, our study focused on synthetic 
provided DNA. Mur ligases were successfully subcloned and expressed in E. coli and insect 
cells.  
 
After the expression, we decided to proceed further work with MurE expressed in E. coli. 
The goal was to detect potential inhibitors isolated from Actinobacteria towards the ligase 
studied. Actinobacteria is source of many antimicrobials. Extracts were not well studied in 
the time of research; thus, some characteristics could be identified. Some of extracts shown 
activity towards E. coli and S. aureus and we wanted to test for potential inhibition of C. 
difficile as well. Fosfomycin and D-cycloserin, as antibiotics in clinical were used to test 
potential inhibitory activity on Mur ligases. Inhibitory assay was carried out to test potential 
of all substances mentioned so far. Unfortunately, no inhibitory activity towards C. difficile 
MurE was acknowledged. Therefore, our prediction that we would find some inhibitors of 
MurE ligase, was denied.  
 
Nevertheless, this work confirms that experiment setting is promising and with detailed 
study of substances used for assay, expression conditions and molecular strategy some new 
inhibitors could be found in the future. 
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7.2  POVZETEK 
 
Clostridium difficile je Gramu pozitivna bakterija. Pri ljudeh je vodilni vzrok driske, ki jo 
povzročata dva eksotoksina. Okužbe s C. difficile (CDI) so najpogosteje posledica uporabe 
antibiotikov, ki sicer niso usmerjeni proti tej bakteriji in praviloma zdravijo druge okužbe 
(Ofosu, 2016). CDI se v večini primerov zdravi z oralnimi antibiotiki, kot sta metronidazol 
in vankomicin. V zadnjem desetletju se je množično pojavila dovzetnost bakterije za te 
antibiotike, saj so se razvili številni odporni sevi. Oba omenjena antibiotika sta široko 
spektralna. Posledica njune uporabe je zmanjšana učinkovitost obrambe pred okužbo, saj 
ima antibiotično zdravljenje velik vpliv tudi na normalno mikrobioto. Prav to pa predstavlja 
glavni klinični problem okužb s C. difficile. Zaradi tega problema je veliko študij usmerjenih 
v iskanje novih potencialnih tarč za nova protimikrobna zdravila, ki bi delovala bolj 
ozkospektralno. Mur ligaze so encimi, ki katalizirajo sintezo peptidoglikana in prestavljajo 
odličen primer novih potencialnih tarč za nova antimikrobna sredstva pri C. difficile. 
 
V ta namen je ta naloga osredotočen na študijo Mur ligaz iz C. difficile. Namen dela je bil 
pridobiti aktivne rekombinantne Mur ligaze iz naravnih sevov C. difficile. Obseg študije je 
bil tekom študije razširjen še na uporabo sintetične DNA za Mur ligaze C. difficile. 
Konstruirali smo plazmide, ki vsebujejo mur gene in ligaze izrazili v prokariontskem in 
evkariontskem sistemu. Mur ligaze pridobljene iz nativne DNA niso pokazale pozitivnih 
rezultatov proteinske ekspresije. Zato se je naša študija osredotočila na sintetično DNA. Mur 
ligaze so bile uspešno klonirane in izražene v E. coli in žuželčjih celicah. 
 
Študijo smo osredotočili na MurE protein. Nadaljnji cilj je bil odkriti potencialne inhibitorje, 
izolirane iz aktinobakterij, proti preučevani ligazi Aktinobakerije so vir številnih 
protimikrobnih zdravil. Ekstrakti v času raziskav niso bili podrobno preučeni in 
identificirani; opredeljene so bile zgolj nekatere značilnosti. Nekateri ekstrakti so pokazali 
protimikrobno aktivnost proti E. coli in S. aureus. Cilj je tako bil preveriti tudi njihovo 
potencialno inhibicijo C. difficile. V testu inhibicije sta bila uporabljena tudi dva antibiotika 
v klinični uporabi, fosfomicin in D-cikloserin. Fosfomicin je znan zaviralec ligaze MurA, 
zato smo želeli preizkusiti tudi morebitno inhibitorno aktivnost proti MurE. Na žalost nismo 
zaznali nobene zaviralne aktivnost nobenega od inhibitorjem proti MurE. Naša hipoteza, da 
bomo v študiji našli nekaj inhibitorjev MurE ligaz, je bila tako zavrnjena. 
 
Kljub zavrnjeni hipotezi to delo potrjuje, da je struktura eksperimenta obetavna in bi s 
podrobno analizo zaviralcev, pogojev proteinske ekspresije in izboljšano molekularno 
strategijo, v prihodnosti lahko našli nove zaviralce Mur ligaz. 
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ANNEX A 
pET28a plasmid map with insert - 
synthetically provided murE gene  
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ANNEX B 
pET28a plasmid map with insert -  
synthetically provided murF gene  
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ANNEX C 
pET28a plasmid map with insert - 
synthetically provided murG gene  
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ANNEX D 
DNA sequence of synthetically provided murE gene 
DNA sequence of synthetically provided murF gene 
 
DNA sequence of synthetically provided murG gene 
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ANNEX E 
Aligned DNA sequences of murC genes amplified from 8 different strains of C. difficile 
 DNA sequencing was performed at Eurofins GATC Biotech GmbH, Köln, 
Germany 
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ANNEX F 
Aligned DNA sequences of murE genes amplified from 8 different strains of C. difficile 
 DNA sequencing was performed at Eurofins GATC Biotech GmbH, Köln, 
Germany 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
